-DOCSTART- -X- -X- O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Consult NN NN O
- NN NN O
Breast NNP NNP B-PROBLEM
Cancer NNP NNP I-PROBLEM
Description NN NN O
: NN NN O
Patient NN NN O
presents NN NN O
with NN NN O
complaint NN NN O
of NN NN O
lump NNP NNP B-PROBLEM
in NN NN O
the NN NN O
upper NN NN O
outer NN NN O
quadrant NN NN O
of NN NN O
the NN NN O
right NN NN O
breast NN NN O
( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
CHIEF NN NN O
COMPLAINT NN NN O
/ NN NN O
REASON NN NN O
FOR NN NN O
THE NN NN O
VISIT NN NN O
: NN NN O
Patient NN NN O
has NN NN O
been NN NN O
diagnosed NN NN O
to NN NN O
have NN NN O
breast NNP NNP B-PROBLEM
cancer NNP NNP I-PROBLEM
. NN NN O

BREAST NN NN O
CANCER NN NN O
HISTORY NN NN O
: NN NN O
Patient NN NN O
presented NN NN O
with NN NN O
the NN NN O
following NN NN O
complaints NN NN O
: NN NN O
Lump NNP NNP B-PROBLEM
in NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
upper NNP NNP I-PROBLEM
outer NNP NNP I-PROBLEM
quadrant NNP NNP I-PROBLEM
of NN NN O
the NN NN O
right NN NN O
breast NN NN O
that NN NN O
has NN NN O
been NN NN O
present NN NN O
for NN NN O
the NN NN O
last NN NN O
4 NN NN O
weeks NN NN O
. NN NN O

The NNP NNP B-PROBLEM
lump NNP NNP I-PROBLEM
is NN NN O
painless NNP NNP B-PROBLEM
and NN NN O
the NNP NNP B-PROBLEM
skin NNP NNP I-PROBLEM
over NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
lump NNP NNP I-PROBLEM
is NN NN O
normal NN NN O
. NN NN O

Patient NN NN O
denies NN NN O
any NNP NNP B-PROBLEM
redness NNP NNP I-PROBLEM
, NN NN O
warmth NNP NNP B-PROBLEM
, NN NN O
edema NNP NNP B-PROBLEM
and NN NN O
nipple NNP NNP B-PROBLEM
discharge NNP NNP I-PROBLEM
. NN NN O

Patient NN NN O
had NN NN O
a NNP NNP B-TEST
mammogram NNP NNP I-TEST
recently NN NN O
and NN NN O
was NN NN O
told NN NN O
to NN NN O
have NN NN O
a NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
measuring NN NN O
2 NN NN O
cm NN NN O
in NN NN O
the NN NN O
UOQ NN NN O
and NN NN O
of NN NN O
the NN NN O
left NN NN O
breast NN NN O
. NN NN O

Patient NN NN O
had NN NN O
an NNP NNP B-TEST
excisional NNP NNP I-TEST
biopsy NNP NNP I-TEST
of NN NN O
the NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
and NN NN O
subsequently NNP NNP B-PROBLEM
axillary NNP NNP I-PROBLEM
nodal NNP NNP I-PROBLEM
sampling NNP NNP I-PROBLEM
. NN NN O

PATHOLOGY NN NN O
: NN NN O
Infiltrating NNP NNP B-PROBLEM
ductal NNP NNP I-PROBLEM
carcinoma NNP NNP I-PROBLEM
, NN NN O
Estrogen NNP NNP B-TEST
receptor NNP NNP I-TEST
56 NN NN O
, NN NN O
Progesterone NNP NNP B-TEST
receptor NNP NNP I-TEST
23 NN NN O
, NN NN O
S-phase NNP NNP B-TEST
fraction NNP NNP I-TEST
2 NN NN O
., NN NN O
Her NNP NNP B-TEST
2 NNP NNP I-TEST
neu NNP NNP I-TEST
0 NN NN O
and NN NN O
all NN NN O
nodes NN NN O
negative NN NN O
. NN NN O

STAGE NN NN O
: NN NN O
Stage NN NN O
I NN NN O
. NN NN O
TNM NN NN O
STAGE NN NN O
: NN NN O
T1 NN NN O
, NN NN O
N0 NNP NNP B-PROBLEM
and NN NN O
M0 NN NN O
. NN NN O

SURGERY NN NN O
: NN NN O
S/P NN NN O
lumpectomy NNP NNP B-TREATMENT
left NNP NNP B-TREATMENT
breast NNP NNP I-TREATMENT
and NNP NNP I-TREATMENT
Left NNP NNP I-TREATMENT
axillary NNP NNP I-TREATMENT
node NNP NNP I-TREATMENT
sampling NNP NNP I-TREATMENT
. NN NN O

Patient NN NN O
is NN NN O
here NN NN O
for NN NN O
further NN NN O
recommendation NN NN O
. NN NN O

PAST NN NN O
MEDICAL NN NN O
HISTORY NN NN O
: NN NN O
Osteoarthritis NNP NNP B-PROBLEM
for NN NN O
5 NN NN O
years NN NN O
. NN NN O

ASHD NNP NNP B-PROBLEM
for NNP NNP B-DURATION
10 NNP NNP I-DURATION
years NNP NNP I-DURATION
. NN NN O

Kidney NNP NNP B-PROBLEM
stones NNP NNP I-PROBLEM
recurrent NN NN O
for NN NN O
10 NN NN O
years NN NN O
. NN NN O

SCREENING NN NN O
TEST NN NN O
HISTORY NN NN O
: NN NN O
Last NNP NNP B-TEST
rectal NNP NNP I-TEST
exam NNP NNP I-TEST
was NN NN O
done NN NN O
on NN NN O
10/99 NNP NNP B-DATE
. NN NN O

Last NNP NNP B-TEST
mammogram NNP NNP I-TEST
was NN NN O
done NN NN O
on NN NN O
12/99 NNP NNP B-DATE
. NN NN O

Last NN NN O
gynecological NNP NNP B-TEST
exam NNP NNP I-TEST
was NN NN O
done NN NN O
on NN NN O
10/99 NNP NNP B-DATE
. NN NN O

Last NNP NNP B-TEST
PAP NNP NNP I-TEST
smear NNP NNP I-TEST
was NN NN O
done NN NN O
on NN NN O
10/99 NNP NNP B-DATE
. NN NN O

Last NNP NNP B-TEST
chest NNP NNP I-TEST
x-ray NNP NNP I-TEST
was NN NN O
done NN NN O
on NN NN O
10/99 NNP NNP B-DATE
. NN NN O

Last NN NN O
F.O.B NN NN O
. NN NN O
was NN NN O
done NN NN O
on NN NN O
10/99-X3 NNP NNP B-DATE
. NN NN O

Last NN NN O
sigmoidoscopy NNP NNP B-TEST
was NN NN O
done NN NN O
on NN NN O
1998 NNP NNP B-DATE
. NN NN O

Last NN NN O
colonoscopy NNP NNP B-TEST
was NN NN O
done NN NN O
on NN NN O
1996 NNP NNP B-DATE
. NN NN O

IMMUNIZATION NN NN O
HISTORY NN NN O
: NN NN O
Last NN NN O
flu NNP NNP B-TREATMENT
vaccine NNP NNP I-TREATMENT
was NN NN O
given NN NN O
on NN NN O
1999 NNP NNP B-DATE
. NN NN O

Last NN NN O
pneumonia NNP NNP B-TREATMENT
vaccine NNP NNP I-TREATMENT
was NN NN O
given NN NN O
on NN NN O
1996 NNP NNP B-DATE
. NN NN O

FAMILY NN NN O
MEDICAL NN NN O
HISTORY NN NN O
: NN NN O
Father NN NN O
age NN NN O
85 NNP NNP B-AGE
, NN NN O
history NN NN O
of NN NN O
cerebrovascular NNP NNP B-PROBLEM
accident NNP NNP I-PROBLEM
( NN NN O
stroke NNP NNP B-PROBLEM
) NNP NNP I-PROBLEM
and NN NN O
hypertension NNP NNP B-PROBLEM
. NN NN O

Mother NN NN O
history NN NN O
of NN NN O
CHF NNP NNP B-PROBLEM
and NN NN O
emphysema NNP NNP B-PROBLEM
that NN NN O
died NN NN O
at NN NN O
the NN NN O
age NN NN O
of NN NN O
78 NNP NNP B-AGE
. NN NN O

No NN NN O
brothers NN NN O
and NN NN O
sisters NN NN O
. NN NN O

1 NN NN O
son NN NN O
healthy NN NN O
at NN NN O
age NN NN O
54 NNP NNP B-AGE
. NN NN O

PAST NN NN O
SURGICAL NN NN O
HISTORY NN NN O
: NN NN O
Appendectomy NNP NNP B-TREATMENT
. NN NN O

Biopsy NNP NNP B-TEST
of NNP NNP I-TEST
the NNP NNP I-TEST
left NNP NNP I-TEST
breast NNP NNP I-TEST
1996 NN NN O
- NN NN O
benign NN NN O
. NN NN O

Cholecystectomy NNP NNP B-TREATMENT
. NN NN O

PERSONAL NN NN O
AND NN NN O
SOCIAL NN NN O
HISTORY NN NN O
: NN NN O
Marital NN NN O
status NN NN O
: NN NN O
Married NN NN O
. NN NN O

Smoking NN NN O
history NN NN O
: NN NN O
Smoked NNP NNP B-PROBLEM
1 NNP NNP I-PROBLEM
PPD NNP NNP I-PROBLEM
, NN NN O
quit NN NN O
12 NN NN O
years NN NN O
ago NN NN O
and NN NN O
after NN NN O
smoking NN NN O
for NN NN O
30 NN NN O
years NN NN O
. NN NN O

Alcohol NN NN O
history NN NN O
: NN NN O
Drinks NN NN O
socially NN NN O
. NN NN O

Denies NN NN O
any NN NN O
history NN NN O
of NN NN O
drug NN NN O
abuse NN NN O
. NN NN O

ALLERGIES NN NN O
: NN NN O
There NN NN O
are NN NN O
no NN NN O
known NNP NNP B-PROBLEM
drug NNP NNP I-PROBLEM
allergies NNP NNP I-PROBLEM
. NN NN O

CURRENT NN NN O
MEDICATIONS NN NN O
: NN NN O
Aspirin NNP NNP B-TREATMENT
1 NNP NNP B-DOSAGE
tab NNP NNP B-FORM
x NN NN O
1 NNP NNP B-DOSAGE
/ NNP NNP I-DOSAGE
day NNP NNP I-DOSAGE
. NN NN O

Calan NNP NNP B-TREATMENT
SR NNP NNP I-TREATMENT
120 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
. NN NN O

x NN NN O
1 NNP NNP B-DOSAGE
/ NNP NNP I-DOSAGE
day NNP NNP I-DOSAGE
. NN NN O

REVIEW NN NN O
OF NN NN O
SYSTEMS NN NN O
: NN NN O
General NN NN O
: NN NN O
Patient NN NN O
feels NN NN O
fairly NN NN O
well NN NN O
. NN NN O

Patient NN NN O
denies NN NN O
history NN NN O
of NN NN O
fever NNP NNP B-PROBLEM
, NN NN O
chills NNP NNP B-PROBLEM
, NN NN O
night NNP NNP B-PROBLEM
sweats NNP NNP I-PROBLEM
and NN NN O
weight NNP NNP B-PROBLEM
loss NNP NNP I-PROBLEM
. NN NN O

Head NN NN O
and NN NN O
Eyes NN NN O
: NN NN O
Patient NN NN O
denies NN NN O
any NNP NNP B-PROBLEM
problems NNP NNP I-PROBLEM
relating NN NN O
to NN NN O
the NN NN O
head NN NN O
and NN NN O
eyes NN NN O
. NN NN O

Ears NN NN O
Nose NN NN O
and NN NN O
Throat NN NN O
: NN NN O
Patient NN NN O
has NN NN O
no NN NN O
problems NNP NNP B-PROBLEM
related NN NN O
to NN NN O
the NN NN O
ears NN NN O
, NN NN O
nose NN NN O
or NN NN O
throat NN NN O
. NN NN O

Respiratory NN NN O
: NN NN O
Patient NN NN O
denies NN NN O
any NNP NNP B-PROBLEM
respiratory NNP NNP I-PROBLEM
complaints NNP NNP I-PROBLEM
, NN NN O
such NN NN O
as NN NN O
cough NNP NNP B-PROBLEM
, NN NN O
shortness NNP NNP B-PROBLEM
of NNP NNP I-PROBLEM
breath NNP NNP I-PROBLEM
, NN NN O
chest NNP NNP B-PROBLEM
pain NNP NNP I-PROBLEM
, NN NN O
wheezing NNP NNP B-PROBLEM
, NN NN O
hemoptysis NNP NNP B-PROBLEM
, NN NN O
etc NN NN O
. NN NN O

Cardiovascular NN NN O
: NN NN O
Chest NNP NNP B-PROBLEM
pain NNP NNP I-PROBLEM
in NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
retrosternal NNP NNP I-PROBLEM
area NNP NNP I-PROBLEM
, NN NN O
Occasional NNP NNP B-PROBLEM
anginal NNP NNP I-PROBLEM
pain NNP NNP I-PROBLEM
and NN NN O
patient NN NN O
describes NN NN O
it NN NN O
as NN NN O
a NN NN O
sensation NN NN O
of NN NN O
tightness NNP NNP B-PROBLEM
. NN NN O

It NN NN O
radiates NN NN O
to NN NN O
the NN NN O
left NN NN O
shoulder NN NN O
. NN NN O

Patient NN NN O
denies NN NN O
any NNP NNP B-PROBLEM
palpitation NNP NNP I-PROBLEM
, NN NN O
syncope NNP NNP B-PROBLEM
, NN NN O
paroxysmal NNP NNP B-PROBLEM
nocturnal NNP NNP I-PROBLEM
dyspnea NNP NNP I-PROBLEM
and NN NN O
orthopnea NNP NNP B-PROBLEM
. NN NN O

Gastrointestinal NN NN O
: NN NN O
Patient NN NN O
denies NN NN O
any NNP NNP B-PROBLEM
nausea NNP NNP I-PROBLEM
, NN NN O
vomiting NNP NNP B-PROBLEM
, NN NN O
abdominal NNP NNP B-PROBLEM
pain NNP NNP I-PROBLEM
, NN NN O
dysphagia NNP NNP B-PROBLEM
or NN NN O
any NNP NNP B-PROBLEM
altered NNP NNP I-PROBLEM
bowel NNP NNP I-PROBLEM
movements NNP NNP I-PROBLEM
. NN NN O

Genitourinary NN NN O
: NN NN O
Denies NN NN O
any NNP NNP B-PROBLEM
genito-urinary NNP NNP I-PROBLEM
complaints NNP NNP I-PROBLEM
. NN NN O

Musculoskeletal NN NN O
: NN NN O
The NN NN O
patient NN NN O
denies NN NN O
any NNP NNP B-PROBLEM
musculoskeletal NNP NNP I-PROBLEM
complaints NNP NNP I-PROBLEM
. NN NN O

Neurological NN NN O
: NN NN O
Patient NN NN O
denies NN NN O
any NNP NNP B-PROBLEM
focal NNP NNP I-PROBLEM
motor NNP NNP I-PROBLEM
, NNP NNP I-PROBLEM
sensory NNP NNP I-PROBLEM
or NNP NNP I-PROBLEM
other NNP NNP I-PROBLEM
neurological NNP NNP I-PROBLEM
symptoms NNP NNP I-PROBLEM
. NN NN O

PHYSICAL NN NN O
EXAMINATION NN NN O
: NN NN O
General NN NN O
: NN NN O
Patient NN NN O
appears NN NN O
well NN NN O
developed NN NN O
, NN NN O
well NN NN O
nourished NN NN O
and NN NN O
healthy NN NN O
. NN NN O

Personality NN NN O
: NN NN O
pleasant NN NN O
and NN NN O
cooperative NN NN O
. NN NN O

Mental NN NN O
status NN NN O
: NN NN O
Alert NN NN O
and NN NN O
oriented NN NN O
. NN NN O

Stature NN NN O
: NN NN O
slender NNP NNP B-PROBLEM
. NN NN O

ECOG NNP NNP B-TEST
performance NNP NNP I-TEST
score NNP NNP I-TEST

0 NN NN O
. NN NN O
HEENT NN NN O
: NN NN O
Examination NNP NNP B-TEST
of NNP NNP I-TEST
head NNP NNP I-TEST
, NNP NNP I-TEST
eyes NNP NNP I-TEST
, NNP NNP I-TEST
ears NNP NNP I-TEST
, NNP NNP I-TEST
nose NNP NNP I-TEST
and NNP NNP I-TEST
throat NNP NNP I-TEST
is NN NN O
unremarkable NN NN O
. NN NN O

Hematologic NN NN O
/ NN NN O
Lymphatic NN NN O
: NN NN O
There NN NN O
is NN NN O
no NN NN O
palpable NNP NNP B-PROBLEM
adenopathy NNP NNP I-PROBLEM
in NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
inguinal NNP NNP I-PROBLEM
, NNP NNP I-PROBLEM
axillary NNP NNP I-PROBLEM
, NNP NNP I-PROBLEM
or NNP NNP I-PROBLEM
cervical NNP NNP I-PROBLEM
areas NNP NNP I-PROBLEM
. NN NN O

Cardiovascular NN NN O
: NN NN O
Heart NN NN O
: NN NN O
Regular NN NN O
rhythm NN NN O
, NN NN O
normal NN NN O
rate NN NN O
without NN NN O
any NNP NNP B-PROBLEM
murmurs NNP NNP I-PROBLEM
or NN NN O
gallops NNP NNP B-PROBLEM
. NN NN O

Breast NN NN O
: NN NN O
RIGHT NN NN O
BREAST NN NN O
: NN NN O
Within NN NN O
normal NN NN O
limits NN NN O
. NN NN O

LEFT NN NN O
BREAST NN NN O
: NN NN O
Consistency NN NN O
: NN NN O
slight NNP NNP B-PROBLEM
induration NNP NNP I-PROBLEM
noted NN NN O
due NN NN O
to NN NN O
recent NNP NNP B-TREATMENT
surgery NNP NNP I-TREATMENT
. NN NN O

Respiratory NN NN O
: NN NN O
Chest NN NN O
symmetrical NN NN O
, NN NN O
normal NN NN O
, NN NN O
breath NN NN O
sounds NN NN O
equal NN NN O
, NN NN O
bilateral NN NN O
symmetrical NN NN O
, NN NN O
no NN NN O
rales NNP NNP B-PROBLEM
or NN NN O
rhonchi NNP NNP B-PROBLEM
and NN NN O
no NN NN O
dullness NNP NNP B-PROBLEM
to NN NN O
percussion NNP NNP B-TEST
. NN NN O

Abdomen NN NN O
/ NN NN O
Gastrointestinal NN NN O
: NN NN O
Abdomen NN NN O
is NN NN O
soft NN NN O
, NN NN O
non-tender NNP NNP B-PROBLEM
, NN NN O
and NN NN O
without NN NN O
palpable NNP NNP B-PROBLEM
masses NNP NNP I-PROBLEM
. NN NN O

No NN NN O
hepatosplenomegaly NNP NNP B-PROBLEM
is NN NN O
appreciable NN NN O
. NN NN O

Extremities NN NN O
: NN NN O
Peripheral NNP NNP B-TEST
pulses NNP NNP I-TEST
are NN NN O
normal NN NN O
. NN NN O

There NN NN O
is NN NN O
no NN NN O
edema NNP NNP B-PROBLEM
, NN NN O
cyanosis NNP NNP B-PROBLEM
, NN NN O
clubbing NNP NNP B-PROBLEM
or NN NN O
significant NNP NNP B-PROBLEM
varicosities NNP NNP I-PROBLEM
. NN NN O

No NN NN O
skin NNP NNP B-PROBLEM
lesions NNP NNP I-PROBLEM
identified NN NN O
. NN NN O

Musculoskelatal NN NN O
: NN NN O
No NN NN O
evidence NN NN O
of NN NN O
joint NNP NNP B-PROBLEM
swelling NNP NNP I-PROBLEM
, NN NN O
bone NNP NNP B-PROBLEM
tenderness NNP NNP I-PROBLEM
or NN NN O
muscle NNP NNP B-PROBLEM
tenderness NNP NNP I-PROBLEM
is NN NN O
appreciable NN NN O
. NN NN O

Neurological NN NN O
: NN NN O
Brief NNP NNP B-TEST
neurological NNP NNP I-TEST
examination NNP NNP I-TEST
reveals NN NN O
motor NN NN O
power NN NN O
grossly NN NN O
normal NN NN O
in NN NN O
all NN NN O
groups NN NN O
and NN NN O
no NN NN O
gross NNP NNP B-PROBLEM
sensory NNP NNP I-PROBLEM
or NNP NNP I-PROBLEM
other NNP NNP I-PROBLEM
abnormality NNP NNP I-PROBLEM
appreciable NN NN O
. NN NN O

RADIOLOGY NN NN O
: NN NN O
Mammogram NNP NNP B-TEST
: NN NN O
A NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
measuring NN NN O
2X2 NN NN O
cm NN NN O
. NN NN O

in NN NN O
the NN NN O
upper NN NN O
outer NN NN O
quadrant NN NN O
of NN NN O
the NN NN O
left NN NN O
breast NN NN O
. NN NN O

Lab NN NN O
: NN NN O
LAB NN NN O
DATA NN NN O
: NN NN O
CMP NN NN O
( NN NN O
comprehensive NN NN O
metabolic NN NN O
panel NN NN O
): NN NN O
WNL NN NN O
. NN NN O

Liver NNP NNP B-TEST
function NNP NNP I-TEST
tests NNP NNP I-TEST
are NN NN O
WNL NN NN O
. NN NN O

CBC NNP NNP B-TEST
with NN NN O
diff NNP NNP B-TEST
shows NN NN O
WBC NNP NNP B-TEST
3.2 NN NN O
/ NN NN O
cmm NN NN O
. NN NN O

Hemoglobin NNP NNP B-TEST
12.0 NN NN O
grams NN NN O
/ NN NN O
dl NN NN O
, NN NN O
Platelets NNP NNP B-TEST
250000 NNP NNP B-STRENGTH
/ NNP NNP I-STRENGTH
cmm NNP NNP I-STRENGTH
and NN NN O
it NN NN O
is NN NN O
dated NN NN O
1/4/2000 NNP NNP B-DATE
. NN NN O

IMPRESSION NN NN O
/ NN NN O
DIAGNOSIS NN NN O
: NN NN O
Carcinoma NNP NNP B-PROBLEM
of NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
left NNP NNP I-PROBLEM
breast NNP NNP I-PROBLEM
( NN NN O
174.9 NN NN O
- NN NN O
female NN NN O
), NN NN O
Upper NNP NNP B-PROBLEM
outer NNP NNP I-PROBLEM
quadrant NNP NNP I-PROBLEM
( NN NN O
174.4 NN NN O
) NN NN O
PATHOLOGY NN NN O
: NN NN O
Infiltrating NNP NNP B-PROBLEM
ductal NNP NNP I-PROBLEM
carcinoma NNP NNP I-PROBLEM
. NN NN O

S/P NN NN O
lumpectomy NNP NNP B-TREATMENT
and NN NN O
axillary NNP NNP B-TREATMENT
node NNP NNP I-TREATMENT
dissection NNP NNP I-TREATMENT
. NN NN O

( NN NN O
Details NN NN O
as NN NN O
per NN NN O
HPI NN NN O
). NN NN O

DISCUSSION NN NN O
: NN NN O
Discussed NN NN O
in NN NN O
detail NN NN O
the NN NN O
diagnosis NN NN O
, NN NN O
prognosis NN NN O
and NN NN O
treatment NN NN O
alternatives NN NN O
. NN NN O

Options NN NN O
of NN NN O
treatment NNP NNP B-TREATMENT
discussed NN NN O
. NN NN O

Side NN NN O
effects NN NN O
of NN NN O
Tamoxifen NNP NNP B-TREATMENT
discussed NN NN O
in NN NN O
detail NN NN O
. NN NN O

RECOMMENDATIONS NN NN O
: NN NN O
Hormonal NNP NNP B-TREATMENT
therapy NNP NNP I-TREATMENT
with NN NN O
Tamoxifen NNP NNP B-TREATMENT
and NN NN O
Radiation NNP NNP B-TREATMENT
therapy NNP NNP I-TREATMENT
to NN NN O
the NN NN O
breast NN NN O
is NN NN O
recommended NN NN O
. NN NN O

TESTS NN NN O
ORDERED NN NN O
: NN NN O
The NN NN O
following NN NN O
labs NNP NNP B-TEST
are NN NN O
to NN NN O
be NN NN O
drawn NN NN O
about NN NN O
a NN NN O
week NN NN O
or NN NN O
so NN NN O
prior NN NN O
to NN NN O
next NN NN O
appointment NN NN O
: NN NN O
HEMATOLOGY NN NN O
: NN NN O
CBC NNP NNP B-TEST
. NN NN O

CHEMISTRY NN NN O
: NN NN O
comprehensive NN NN O
metabolic NN NN O
panel NN NN O
( NN NN O
CMP NNP NNP B-TEST
) NNP NNP I-TEST
and NN NN O
liver NNP NNP B-TEST
function NNP NNP I-TEST
panel NNP NNP I-TEST
( NN NN O
LFT NNP NNP B-TEST
). NN NN O

MEDICATIONS NNP NNP B-TREATMENT
PRESCRIBED NNP NNP I-TREATMENT
: NN NN O
Nolvadex NNP NNP B-TREATMENT
20 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
. NN NN O

1 NNP NNP B-FREQUENCY
time NNP NNP I-FREQUENCY
a NNP NNP I-FREQUENCY
day NNP NNP I-FREQUENCY
. NN NN O

FOLLOW-UP NN NN O
INSTRUCTIONS NN NN O
: NN NN O
Return NN NN O
to NN NN O
see NN NN O
William NNP NNP B-NAME
Smith NNP NNP I-NAME
. NN NN O

M.D NN NN O
. NN NN O
for NN NN O
follow NN NN O
up NN NN O
in NN NN O
3 NN NN O
month NN NN O

( NN NN O
s NN NN O
). NN NN O

Make NN NN O
appointment NN NN O
to NN NN O
Radiation NN NN O
therapy NN NN O
. NN NN O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Hematology NN NN O
Consult NN NN O
- NN NN O
1 NN NN O
Description NN NN O
: NN NN O
Markedly NNP NNP B-PROBLEM
elevated NNP NNP I-PROBLEM
PT NNP NNP I-PROBLEM
INR NNP NNP I-PROBLEM
despite NN NN O
stopping NN NN O
Coumadin NNP NNP B-TREATMENT
and NN NN O
administering NN NN O
vitamin NNP NNP B-TREATMENT
K NNP NNP I-TREATMENT
. NN NN O

Patient NN NN O
with NN NN O
a NN NN O
history NN NN O
of NN NN O
iron-deficiency NNP NNP B-PROBLEM
anemia NNP NNP I-PROBLEM
due NN NN O
to NN NN O
chronic NNP NNP B-PROBLEM
blood NNP NNP I-PROBLEM
loss NNP NNP I-PROBLEM
from NN NN O
colitis NNP NNP B-PROBLEM
. NN NN O

( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
HISTORY NN NN O
OF NN NN O
PRESENT NN NN O
ILLNESS NN NN O
: NN NN O
The NN NN O
patient NN NN O
is NN NN O
well NN NN O
known NN NN O
to NN NN O
me NN NN O
for NN NN O
a NN NN O
history NN NN O
of NN NN O
iron-deficiency NNP NNP B-PROBLEM
anemia NNP NNP I-PROBLEM
due NN NN O
to NN NN O
chronic NNP NNP B-PROBLEM
blood NNP NNP I-PROBLEM
loss NNP NNP I-PROBLEM
from NN NN O
colitis NNP NNP B-PROBLEM
. NN NN O

We NN NN O
corrected NN NN O
her NNP NNP B-TEST
hematocrit NNP NNP I-TEST
last NN NN O
year NN NN O
with NN NN O
intravenous NNP NNP B-TREATMENT
( NNP NNP I-TREATMENT
IV NNP NNP I-TREATMENT
) NNP NNP I-TREATMENT
iron NNP NNP I-TREATMENT
. NN NN O

Ultimately NN NN O
, NN NN O
she NN NN O
had NN NN O
a NNP NNP B-TREATMENT
total NNP NNP I-TREATMENT
proctocolectomy NNP NNP I-TREATMENT
done NN NN O
on NN NN O
03/14/2007 NNP NNP B-DATE
to NN NN O
treat NN NN O
her NNP NNP B-PROBLEM
colitis NNP NNP I-PROBLEM
. NN NN O

Her NN NN O
course NN NN O
has NN NN O
been NN NN O
very NN NN O
complicated NN NN O
since NN NN O
then NN NN O
with NN NN O
needing NN NN O
multiple NNP NNP B-TREATMENT
surgeries NNP NNP I-TREATMENT
for NN NN O
removal NNP NNP B-TREATMENT
of NN NN O
hematoma NNP NNP B-PROBLEM
. NN NN O

This NN NN O
is NN NN O
partly NN NN O
because NN NN O
she NN NN O
was NN NN O
on NN NN O
anticoagulation NNP NNP B-TREATMENT
for NN NN O
a NNP NNP B-PROBLEM
right NNP NNP I-PROBLEM
arm NNP NNP I-PROBLEM
deep NNP NNP I-PROBLEM
venous NNP NNP I-PROBLEM
thrombosis NNP NNP I-PROBLEM
( NNP NNP I-PROBLEM
DVT NNP NNP I-PROBLEM
) NNP NNP I-PROBLEM
she NN NN O
had NN NN O
early NN NN O
this NN NN O
year NN NN O
, NN NN O
complicated NN NN O
by NN NN O
septic NNP NNP B-PROBLEM
phlebitis NNP NNP I-PROBLEM
. NN NN O

Chart NN NN O
was NN NN O
reviewed NN NN O
, NN NN O
and NN NN O
I NN NN O
will NN NN O
not NN NN O
reiterate NN NN O
her NN NN O
complex NN NN O
history NN NN O
. NN NN O

I NN NN O
am NN NN O
asked NN NN O
to NN NN O
see NN NN O
the NN NN O
patient NN NN O
again NN NN O
because NN NN O
of NN NN O
concerns NN NN O
for NN NN O
coagulopathy NNP NNP B-PROBLEM
. NN NN O

She NN NN O
had NN NN O
surgery NNP NNP B-TREATMENT
again NN NN O
last NN NN O
month NN NN O
to NN NN O
evacuate NN NN O
a NNP NNP B-PROBLEM
pelvic NNP NNP I-PROBLEM
hematoma NNP NNP I-PROBLEM
, NN NN O
and NN NN O
was NN NN O
found NN NN O
to NN NN O
have NN NN O
vancomycin NNP NNP B-PROBLEM
resistant NNP NNP I-PROBLEM
enterococcus NNP NNP I-PROBLEM
, NN NN O
for NN NN O
which NN NN O
she NN NN O
is NN NN O
on NN NN O
multiple NNP NNP B-TREATMENT
antibiotics NNP NNP I-TREATMENT
and NN NN O
followed NN NN O
by NN NN O
infectious NNP NNP B-PROBLEM
disease NNP NNP I-PROBLEM
now NN NN O
. NN NN O

She NN NN O
is NN NN O
on NN NN O
total NNP NNP B-TREATMENT
parenteral NNP NNP I-TREATMENT
nutrition NNP NNP I-TREATMENT
( NN NN O
TPN NNP NNP B-TREATMENT
) NN NN O
as NN NN O
well NN NN O
. NN NN O

LABORATORY NN NN O
DATA NN NN O
: NN NN O
Labs NNP NNP B-TEST
today NN NN O
showed NN NN O
a NNP NNP B-TEST
white NNP NNP I-TEST
blood NNP NNP I-TEST
count NNP NNP I-TEST
of NN NN O
7.9 NN NN O
, NN NN O
hemoglobin NNP NNP B-TEST
11.0 NN NN O
, NN NN O
hematocrit NNP NNP B-TEST
32.8 NN NN O
, NN NN O
and NN NN O
platelets NNP NNP B-TEST
1,121,000 NN NN O
. NN NN O

MCV NNP NNP B-TEST
is NN NN O

89 NN NN O
. NN NN O
Her NNP NNP B-TEST
platelets NNP NNP I-TEST
have NN NN O
been NN NN O
elevated NNP NNP B-PROBLEM
for NN NN O
at NN NN O
least NN NN O
the NN NN O
past NN NN O
week NN NN O
, NN NN O
with NN NN O
counts NNP NNP B-TEST
initially NN NN O
at NN NN O
the NN NN O
600,000 NN NN O
to NN NN O
700,000 NN NN O
range NN NN O
and NN NN O
in NN NN O
the NN NN O
last NN NN O
couple NN NN O
of NN NN O
day NN NN O
rising NN NN O
above NN NN O
1,000,000 NN NN O
. NN NN O

Her NNP NNP B-TEST
hematocrit NNP NNP I-TEST
has NN NN O
been NN NN O
essentially NN NN O
stable NN NN O
for NN NN O
the NN NN O
past NN NN O
month NN NN O
or NN NN O
so NN NN O
. NN NN O

White NNP NNP B-TEST
blood NNP NNP I-TEST
count NNP NNP I-TEST
has NN NN O
improved NN NN O
. NN NN O

PT NNP NNP B-TEST
has NN NN O
been NN NN O
markedly NNP NNP B-PROBLEM
elevated NNP NNP I-PROBLEM
and NN NN O
today NN NN O
is NN NN O
44.9 NN NN O
with NN NN O
an NNP NNP B-TEST
INR NNP NNP I-TEST
of NN NN O
5.0 NN NN O
. NN NN O

This NN NN O
is NN NN O
despite NN NN O
stopping NN NN O
Coumadin NNP NNP B-TREATMENT
on NN NN O
05/31/2007 NNP NNP B-DATE
, NN NN O
and NN NN O
with NN NN O
administration NN NN O
of NN NN O
vitamin NNP NNP B-TREATMENT
K NNP NNP I-TREATMENT
via NN NN O
the NNP NNP B-TREATMENT
TPN NNP NNP I-TREATMENT
, NN NN O
as NN NN O
well NN NN O
as NN NN O
additional NNP NNP B-TREATMENT
doses NNP NNP I-TREATMENT
IV NNP NNP I-TREATMENT
. NN NN O

The NNP NNP B-TEST
PT NNP NNP I-TEST
is NN NN O
slightly NN NN O
improved NN NN O
over NN NN O
the NN NN O
last NN NN O
few NN NN O
days NN NN O
, NN NN O
being NN NN O
high NNP NNP B-PROBLEM
at NN NN O
65.0 NN NN O
with NN NN O
an NNP NNP B-TEST
INR NNP NNP I-TEST
of NN NN O
7.3 NN NN O
yesterday NN NN O
. NN NN O

PTT NNP NNP B-TEST
has NN NN O
not NN NN O
been NN NN O
checked NN NN O
since NN NN O
05/18/2007 NNP NNP B-DATE
and NN NN O
was NN NN O
normal NN NN O
then NN NN O
at NN NN O

28 NN NN O
. NN NN O
LFTs NNP NNP B-TEST
have NN NN O
been NN NN O
elevated NNP NNP B-PROBLEM
. NN NN O

ALT NNP NNP B-TEST
is NN NN O
100 NN NN O
, NN NN O
AST NNP NNP B-TEST
57 NN NN O
, NN NN O
GGT NNP NNP B-TEST
226 NN NN O
, NN NN O
alkaline NNP NNP B-TEST
phosphatase NNP NNP I-TEST
505 NN NN O
, NN NN O
albumin NNP NNP B-PROBLEM
low NNP NNP I-PROBLEM
at NN NN O
3.3 NN NN O
, NN NN O
uric NNP NNP B-PROBLEM
acid NNP NNP I-PROBLEM
high NNP NNP I-PROBLEM
at NN NN O
4.9 NN NN O
, NN NN O
bilirubin NNP NNP B-TEST
normal NN NN O
, NN NN O
LDH NNP NNP B-TEST
normal NN NN O
, NN NN O
and NN NN O
pre-albumin NNP NNP B-PROBLEM
low NNP NNP I-PROBLEM
at NN NN O

16 NN NN O
. NN NN O
Creatinine NNP NNP B-TEST
is NN NN O
at NN NN O
1.5 NN NN O
, NN NN O
with NN NN O
an NNP NNP B-PROBLEM
estimated NNP NNP I-PROBLEM
creatinine NNP NNP I-PROBLEM
clearance NNP NNP I-PROBLEM
low NNP NNP I-PROBLEM
at NN NN O
41.7 NN NN O
. NN NN O

Other NNP NNP B-TEST
electrolytes NNP NNP I-TEST
are NN NN O
fairly NN NN O
normal NN NN O
. NN NN O

B12 NNP NNP B-TEST
was NN NN O
assessed NN NN O
on NN NN O
05/19/2007 NNP NNP B-DATE
and NN NN O
was NN NN O
normal NN NN O
at NN NN O
941 NN NN O
. NN NN O

Folic NNP NNP B-TEST
acid NNP NNP I-TEST
was NN NN O
normal NN NN O
. NN NN O

Iron NNP NNP B-TEST
saturation NNP NNP I-TEST
has NN NN O
not NN NN O
been NN NN O
checked NN NN O
since NN NN O
March NNP NNP B-DATE
, NN NN O
and NN NN O
was NN NN O
normal NN NN O
then NN NN O
. NN NN O

Ferritin NNP NNP B-TEST
has NN NN O
not NN NN O
been NN NN O
checked NN NN O
in NN NN O
a NN NN O
couple NN NN O
of NN NN O
months NN NN O
. NN NN O

CURRENT NN NN O
MEDICATIONS NN NN O
: NN NN O
Erythropoietin NNP NNP B-TREATMENT
45,000 NNP NNP B-STRENGTH
units NNP NNP I-STRENGTH
every NNP NNP B-FREQUENCY
week NNP NNP I-FREQUENCY
, NN NN O
started NN NN O
05/16/2007 NNP NNP B-DATE
. NN NN O

She NN NN O
is NN NN O
on NN NN O
heparin NNP NNP B-TREATMENT
flushes NNP NNP I-TREATMENT
, NN NN O
loperamide NNP NNP B-TREATMENT
, NN NN O
niacin NNP NNP B-TREATMENT
, NN NN O
pantoprazole NNP NNP B-TREATMENT
, NN NN O
Diovan NNP NNP B-TREATMENT
, NN NN O
Afrin NNP NNP B-TREATMENT
nasal NNP NNP I-TREATMENT
spray NNP NNP I-TREATMENT
, NN NN O
caspofungin NNP NNP B-TREATMENT
, NN NN O
daptomycin NNP NNP B-TREATMENT
, NN NN O
Ertapenem NNP NNP B-TREATMENT
, NN NN O
fentanyl NNP NNP B-TREATMENT
or NN NN O
morphine NNP NNP B-TREATMENT
p.r.n NNP NNP B-FREQUENCY
. NN NN O

pain NNP NNP B-PROBLEM
, NN NN O
and NN NN O
Compazine NNP NNP B-TREATMENT
or NN NN O
Zofran NNP NNP B-TREATMENT
p.r.n NNP NNP B-FREQUENCY
. NN NN O

nausea NNP NNP B-PROBLEM
. NN NN O

PHYSICAL NN NN O
EXAMINATION NN NN O
: NN NN O
GENERAL NN NN O
: NN NN O
She NN NN O
is NN NN O
alert NN NN O
, NN NN O
and NN NN O
frustrated NN NN O
with NN NN O
her NN NN O
prolonged NN NN O
hospital NN NN O
stay NN NN O
. NN NN O

She NN NN O
notes NN NN O
that NN NN O
she NN NN O
had NN NN O
epistaxis NNP NNP B-PROBLEM
a NN NN O
few NN NN O
days NN NN O
ago NN NN O
, NN NN O
requiring NN NN O
nasal NNP NNP B-TREATMENT
packing NNP NNP I-TREATMENT
and NN NN O
fortunately NN NN O
that NN NN O
had NN NN O
resolved NN NN O
now NN NN O
. NN NN O

VITAL NN NN O
SIGNS NN NN O
: NN NN O
Today NN NN O
, NN NN O
temperature NNP NNP B-TEST
is NN NN O
98.5 NN NN O
, NN NN O
pulse NNP NNP B-TEST
99 NN NN O
, NN NN O
respirations NNP NNP B-TEST
16 NN NN O
, NN NN O
blood NNP NNP B-TEST
pressure NNP NNP I-TEST
105/65 NN NN O
, NN NN O
and NN NN O
pulse NNP NNP B-TEST
is NN NN O

95 NN NN O
. NN NN O
She NN NN O
is NN NN O
not NN NN O
requiring NN NN O
oxygen NNP NNP B-TREATMENT
. NN NN O

SKIN NN NN O
: NN NN O
No NN NN O
significant NNP NNP B-PROBLEM
ecchymoses NNP NNP I-PROBLEM
are NN NN O
noted NN NN O
. NN NN O

ABDOMEN NN NN O
: NN NN O
Ileostomy NNP NNP B-TREATMENT
is NN NN O
in NN NN O
place NN NN O
, NN NN O
with NN NN O
greenish NNP NNP B-PROBLEM
black NNP NNP I-PROBLEM
liquid NNP NNP I-PROBLEM
output NNP NNP I-PROBLEM
. NN NN O

Midline NNP NNP B-PROBLEM
surgical NNP NNP I-PROBLEM
scar NNP NNP I-PROBLEM
has NN NN O
healed NN NN O
well NN NN O
, NN NN O
with NN NN O
a NNP NNP B-TREATMENT
dressing NNP NNP I-TREATMENT
in NN NN O
place NN NN O
in NN NN O
the NN NN O
middle NN NN O
, NN NN O
with NN NN O
no NN NN O
bleeding NNP NNP B-PROBLEM
noted NN NN O
. NN NN O

EXTREMITIES NN NN O
: NN NN O
She NN NN O
has NN NN O
no NN NN O
peripheral NNP NNP B-PROBLEM
edema NNP NNP I-PROBLEM
. NN NN O

CARDIAC NN NN O
: NN NN O
Regular NN NN O
rate NN NN O
. NN NN O

LYMPHATICS NNP NNP B-PROBLEM
: NN NN O
No NN NN O
adenopathy NNP NNP B-PROBLEM
is NN NN O
noted NN NN O
. NN NN O

LUNGS NN NN O
: NN NN O
Clear NN NN O
bilaterally NN NN O
. NN NN O

IMPRESSION NN NN O
AND NN NN O
PLAN NN NN O
: NN NN O
Markedly NNP NNP B-PROBLEM
elevated NNP NNP I-PROBLEM
PT/INR NNP NNP I-PROBLEM
despite NN NN O
stopping NN NN O
Coumadin NNP NNP B-TREATMENT
and NN NN O
administering NN NN O
vitamin NNP NNP B-TREATMENT
K NNP NNP I-TREATMENT
. NN NN O

I NN NN O
will NN NN O
check NN NN O
mixing NNP NNP B-TEST
studies NNP NNP I-TEST
to NN NN O
see NN NN O
if NN NN O
she NN NN O
has NN NN O
deficiency NNP NNP B-PROBLEM
, NN NN O
which NN NN O
could NN NN O
be NN NN O
due NN NN O
to NN NN O
poor NNP NNP B-PROBLEM
production NNP NNP I-PROBLEM
given NN NN O
her NNP NNP B-PROBLEM
elevated NNP NNP I-PROBLEM
LFTs NNP NNP I-PROBLEM
, NN NN O
decreased NNP NNP B-PROBLEM
albumin NNP NNP I-PROBLEM
, NN NN O
and NN NN O
decreased NNP NNP B-PROBLEM
pre-albumin NNP NNP I-PROBLEM
. NN NN O

It NN NN O
is NN NN O
possible NN NN O
that NN NN O
she NN NN O
has NN NN O
an NNP NNP B-TREATMENT
inhibitor NNP NNP I-TREATMENT
, NN NN O
which NN NN O
would NN NN O
have NN NN O
to NN NN O
be NN NN O
an NNP NNP B-TREATMENT
acquired NNP NNP I-TREATMENT
inhibitor NNP NNP I-TREATMENT
, NN NN O
generally NN NN O
presenting NN NN O
with NN NN O
an NNP NNP B-PROBLEM
elevated NNP NNP I-PROBLEM
PTT NNP NNP I-PROBLEM
and NN NN O
not NN NN O
PT NNP NNP B-PROBLEM
. NN NN O

I NN NN O
will NN NN O
check NN NN O
a NNP NNP B-TEST
PTT NNP NNP I-TEST
and NN NN O
check NN NN O
mixing NNP NNP B-TEST
studies NNP NNP I-TEST
if NN NN O
that NN NN O
is NN NN O
prolonged NN NN O
. NN NN O

It NN NN O
is NN NN O
doubtful NN NN O
that NN NN O
she NN NN O
has NN NN O
a NNP NNP B-TREATMENT
lupus NNP NNP I-TREATMENT
anticoagulant NNP NNP I-TREATMENT
since NN NN O
she NN NN O
has NN NN O
been NN NN O
presenting NN NN O
with NN NN O
bleeding NNP NNP B-PROBLEM
symptoms NNP NNP I-PROBLEM
rather NN NN O
than NN NN O
clotting NN NN O
. NN NN O

I NN NN O
agree NN NN O
with NN NN O
continuing NN NN O
off NN NN O
of NN NN O
anticoagulation NNP NNP B-TREATMENT
for NN NN O
now NN NN O
. NN NN O

She NN NN O
has NN NN O
markedly NNP NNP B-PROBLEM
elevated NNP NNP I-PROBLEM
platelet NNP NNP I-PROBLEM
count NNP NNP I-PROBLEM
. NN NN O

I NN NN O
suspect NN NN O
this NN NN O
is NN NN O
likely NN NN O
reactive NN NN O
to NN NN O
infection NNP NNP B-PROBLEM
, NN NN O
and NN NN O
not NN NN O
from NN NN O
a NNP NNP B-PROBLEM
new NNP NNP I-PROBLEM
myeloproliferative NNP NNP I-PROBLEM
disorder NNP NNP I-PROBLEM
. NN NN O

Anemia NNP NNP B-PROBLEM
has NN NN O
been NN NN O
stable NN NN O
, NN NN O
and NN NN O
is NN NN O
multifactorial NN NN O
. NN NN O

Given NN NN O
her NNP NNP B-PROBLEM
decreased NNP NNP I-PROBLEM
creatinine NNP NNP I-PROBLEM
clearance NNP NNP I-PROBLEM
, NN NN O
I NN NN O
agree NN NN O
with NN NN O
erythropoietin NNP NNP B-TREATMENT
support NNP NNP I-TREATMENT
. NN NN O

She NN NN O
was NN NN O
iron NNP NNP B-PROBLEM
deficient NNP NNP I-PROBLEM
last NN NN O
year NN NN O
, NN NN O
and NN NN O
with NN NN O
her NNP NNP B-TREATMENT
multiple NNP NNP I-TREATMENT
surgeries NNP NNP I-TREATMENT
and NN NN O
poor NN NN O
p.o NN NN O
. NN NN O
intake NN NN O
, NN NN O
may NN NN O
have NN NN O
become NN NN O
iron NNP NNP B-PROBLEM
deficient NNP NNP I-PROBLEM
again NN NN O
. NN NN O

She NN NN O
has NN NN O
had NN NN O
part NN NN O
of NN NN O
her NN NN O
small NN NN O
bowel NN NN O
removed NN NN O
, NN NN O
so NN NN O
there NN NN O
may NN NN O
be NN NN O
a NN NN O
component NN NN O
of NN NN O
poor NNP NNP B-PROBLEM
absorption NNP NNP I-PROBLEM
as NN NN O
well NN NN O
. NN NN O

If NN NN O
she NN NN O
is NN NN O
iron NNP NNP B-PROBLEM
deficient NNP NNP I-PROBLEM
, NN NN O
this NN NN O
may NN NN O
contribute NN NN O
also NN NN O
to NN NN O
her NNP NNP B-PROBLEM
elevated NNP NNP I-PROBLEM
platelet NNP NNP I-PROBLEM
counts NNP NNP I-PROBLEM
. NN NN O

I NN NN O
will NN NN O
check NN NN O
a NNP NNP B-TEST
ferritin NNP NNP I-TEST
. NN NN O

This NN NN O
may NN NN O
be NN NN O
difficult NN NN O
to NN NN O
interpret NN NN O
because NN NN O
of NN NN O
inflammation NNP NNP B-PROBLEM
. NN NN O

If NN NN O
it NN NN O
is NN NN O
decreased NN NN O
, NN NN O
plan NN NN O
will NN NN O
be NN NN O
to NN NN O
add NN NN O
iron NNP NNP B-TREATMENT
supplementation NNP NNP I-TREATMENT
intravenously NNP NNP I-TREATMENT
. NN NN O

If NN NN O
it NN NN O
is NN NN O
elevated NNP NNP B-PROBLEM
, NN NN O
we NN NN O
could NN NN O
consider NN NN O
a NNP NNP B-TEST
bone NNP NNP I-TEST
marrow NNP NNP I-TEST
biopsy NNP NNP I-TEST
to NN NN O
evaluate NN NN O
her NNP NNP B-PROBLEM
iron NNP NNP I-PROBLEM
stores NNP NNP I-PROBLEM
, NN NN O
and NN NN O
also NN NN O
assess NN NN O
her NNP NNP B-PROBLEM
myelopoiesis NNP NNP I-PROBLEM
given NN NN O
the NNP NNP B-PROBLEM
markedly NNP NNP I-PROBLEM
elevated NNP NNP I-PROBLEM
platelet NNP NNP I-PROBLEM
counts NNP NNP I-PROBLEM
. NN NN O

She NN NN O
needs NN NN O
continued NNP NNP B-TREATMENT
treatment NNP NNP I-TREATMENT
as NN NN O
you NN NN O
are NN NN O
for NN NN O
her NNP NNP B-PROBLEM
infections NNP NNP I-PROBLEM
. NN NN O

I NN NN O
will NN NN O
discuss NN NN O
the NN NN O
case NN NN O
with NN NN O
Dr NN NN O
. NN NN O
X NN NN O
as NN NN O
well NN NN O
since NN NN O
there NN NN O
is NN NN O
a NN NN O
question NN NN O
as NN NN O
to NN NN O
whether NN NN O
she NN NN O
might NN NN O
need NN NN O
additional NNP NNP B-TREATMENT
surgery NNP NNP I-TREATMENT
. NN NN O

She NN NN O
is NN NN O
not NN NN O
a NN NN O
surgical NN NN O
candidate NN NN O
now NN NN O
with NN NN O
her NNP NNP B-PROBLEM
elevated NNP NNP I-PROBLEM
PT/INR NNP NNP I-PROBLEM
. NN NN O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Discharge NN NN O
Summary NN NN O
- NN NN O
Mesothelioma NN NN O
- NN NN O
1 NN NN O
Description NN NN O
: NN NN O
Mesothelioma NNP NNP B-PROBLEM
, NN NN O
pleural NNP NNP B-PROBLEM
effusion NNP NNP I-PROBLEM
, NN NN O
atrial NNP NNP B-PROBLEM
fibrillation NNP NNP I-PROBLEM
, NN NN O
anemia NNP NNP B-PROBLEM
, NN NN O
ascites NNP NNP B-PROBLEM
, NN NN O
esophageal NNP NNP B-PROBLEM
reflux NNP NNP I-PROBLEM
, NN NN O
and NN NN O
history NN NN O
of NN NN O
deep NNP NNP B-PROBLEM
venous NNP NNP I-PROBLEM
thrombosis NNP NNP I-PROBLEM
. NN NN O

( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
PRINCIPAL NN NN O
DIAGNOSIS NN NN O
: NN NN O
Mesothelioma NNP NNP B-PROBLEM
. NN NN O

SECONDARY NN NN O
DIAGNOSES NN NN O
: NN NN O
Pleural NNP NNP B-PROBLEM
effusion NNP NNP I-PROBLEM
, NN NN O
atrial NNP NNP B-PROBLEM
fibrillation NNP NNP I-PROBLEM
, NN NN O
anemia NNP NNP B-PROBLEM
, NN NN O
ascites NNP NNP B-PROBLEM
, NN NN O
esophageal NNP NNP B-PROBLEM
reflux NNP NNP I-PROBLEM
, NN NN O
and NN NN O
history NN NN O
of NN NN O
deep NNP NNP B-PROBLEM
venous NNP NNP I-PROBLEM
thrombosis NNP NNP I-PROBLEM
. NN NN O

PROCEDURES NN NN O

1 NN NN O
. NN NN O
On NN NN O
August NNP NNP B-DATE
24 NNP NNP I-DATE
, NNP NNP I-DATE
2007 NNP NNP I-DATE
, NN NN O
decortication NNP NNP B-TREATMENT
of NNP NNP I-TREATMENT
the NNP NNP I-TREATMENT
lung NNP NNP I-TREATMENT
with NN NN O
pleural NNP NNP B-TEST
biopsy NNP NNP I-TEST
and NN NN O
transpleural NNP NNP B-TEST
fluoroscopy NNP NNP I-TEST
. NN NN O

2 NN NN O
. NN NN O
On NN NN O
August NNP NNP B-DATE
20 NNP NNP I-DATE
, NNP NNP I-DATE
2007 NNP NNP I-DATE
, NN NN O
thoracentesis NNP NNP B-TREATMENT
. NN NN O

3 NN NN O
. NN NN O
On NN NN O
August NNP NNP B-DATE
31 NNP NNP I-DATE
, NNP NNP I-DATE
2007 NNP NNP I-DATE
, NN NN O
Port-A-Cath NNP NNP B-TREATMENT
placement NNP NNP I-TREATMENT
. NN NN O

HISTORY NN NN O
AND NN NN O
PHYSICAL NN NN O
: NN NN O
The NN NN O
patient NN NN O
is NN NN O
a NN NN O
41-year-old NNP NNP B-AGE
Vietnamese NNP NNP B-LOCATION
female NN NN O
with NN NN O
a NNP NNP B-PROBLEM
nonproductive NNP NNP I-PROBLEM
cough NNP NNP I-PROBLEM
that NN NN O
started NN NN O
last NN NN O
week NN NN O
. NN NN O

She NN NN O
has NN NN O
had NN NN O
right-sided NNP NNP B-PROBLEM
chest NNP NNP I-PROBLEM
pain NNP NNP I-PROBLEM
radiating NN NN O
to NN NN O
her NN NN O
back NN NN O
with NN NN O
fever NNP NNP B-PROBLEM
starting NN NN O
yesterday NN NN O
. NN NN O

She NN NN O
has NN NN O
a NN NN O
history NN NN O
of NN NN O
pericarditis NNP NNP B-PROBLEM
and NN NN O
pericardectomy NNP NNP B-TREATMENT
in NN NN O
May NNP NNP B-DATE
2006 NNP NNP I-DATE
and NN NN O
developed NN NN O
cough NNP NNP B-PROBLEM
with NN NN O
right-sided NNP NNP B-PROBLEM
chest NNP NNP I-PROBLEM
pain NNP NNP I-PROBLEM
, NN NN O
and NN NN O
went NN NN O
to NN NN O
an NN NN O
urgent NN NN O
care NN NN O
center NN NN O
. NN NN O

Chest NNP NNP B-TEST
x-ray NNP NNP I-TEST
revealed NN NN O
right-sided NNP NNP B-PROBLEM
pleural NNP NNP I-PROBLEM
effusion NNP NNP I-PROBLEM
. NN NN O

PAST NN NN O
MEDICAL NN NN O
HISTORY NN NN O

1 NN NN O
. NN NN O
Pericardectomy NNP NNP B-TREATMENT
. NN NN O

2 NN NN O
. NN NN O
Pericarditis NNP NNP B-PROBLEM
. NN NN O

2 NN NN O
. NN NN O
Atrial NNP NNP B-PROBLEM
fibrillation NNP NNP I-PROBLEM
. NN NN O

4 NN NN O
. NN NN O
RNCA NN NN O
with NN NN O
intracranial NNP NNP B-TREATMENT
thrombolytic NNP NNP I-TREATMENT
treatment NNP NNP I-TREATMENT
. NN NN O

5 NN NN O
PTA NN NN O
of NN NN O
MCA NN NN O
. NN NN O

6 NN NN O
. NN NN O
Mesenteric NNP NNP B-PROBLEM
venous NNP NNP I-PROBLEM
thrombosis NNP NNP I-PROBLEM
. NN NN O

7 NN NN O
. NN NN O
Pericardial NNP NNP B-TREATMENT
window NNP NNP I-TREATMENT
. NN NN O

8 NN NN O
. NN NN O
Cholecystectomy NNP NNP B-TREATMENT
. NN NN O

9 NN NN O
. NN NN O
Left NNP NNP B-TEST
thoracentesis NNP NNP I-TEST
. NN NN O

FAMILY NN NN O
HISTORY NN NN O
: NN NN O
No NN NN O
family NN NN O
history NN NN O
of NN NN O
coronary NNP NNP B-PROBLEM
artery NNP NNP I-PROBLEM
disease NNP NNP I-PROBLEM
, NN NN O
CVA NNP NNP B-PROBLEM
, NN NN O
diabetes NNP NNP B-PROBLEM
, NN NN O
CHF NNP NNP B-PROBLEM
or NN NN O
MI NNP NNP B-PROBLEM
. NN NN O

The NN NN O
patient NN NN O
has NN NN O
one NN NN O
family NN NN O
member NN NN O
, NN NN O
a NN NN O
sister NN NN O
, NN NN O
with NN NN O
history NN NN O
of NN NN O
cancer NNP NNP B-PROBLEM
. NN NN O

SOCIAL NN NN O
HISTORY NN NN O
: NN NN O
She NN NN O
is NN NN O
married NN NN O
. NN NN O

Employed NN NN O
with NN NN O
the NN NN O
US NNP NNP B-LOCATION
Post NNP NNP I-LOCATION
Office NNP NNP I-LOCATION
. NN NN O

She NN NN O
is NN NN O
a NN NN O
mother NN NN O
of NN NN O
three NN NN O
. NN NN O

Denies NN NN O
tobacco NN NN O
, NN NN O
alcohol NN NN O
or NN NN O
illicit NN NN O
drug NN NN O
use NN NN O
. NN NN O

MEDICATIONS NN NN O

1 NN NN O
. NN NN O
Coumadin NNP NNP B-TREATMENT
1 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
daily NNP NNP B-FREQUENCY
. NN NN O

Last NN NN O
INR NNP NNP B-TEST
was NN NN O
on NN NN O
Tuesday NNP NNP B-DATE
, NN NN O
August NNP NNP B-DATE
14 NNP NNP I-DATE
, NNP NNP I-DATE
2007 NNP NNP I-DATE
, NN NN O
and NN NN O
her NNP NNP B-TEST
INR NNP NNP I-TEST
was NN NN O
2.3 NN NN O
. NN NN O

2 NN NN O
. NN NN O
Amiodarone NNP NNP B-TREATMENT
100 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
p.o NNP NNP B-ROUTE
. NN NN O

daily NNP NNP B-FREQUENCY
. NN NN O

REVIEW NN NN O
OF NN NN O
SYSTEMS NN NN O
: NN NN O
Complete NN NN O
review NN NN O
of NN NN O
systems NNP NNP B-TEST
negative NN NN O
except NN NN O
as NN NN O
in NN NN O
pulmonary NN NN O
as NN NN O
noted NN NN O
above NN NN O
. NN NN O

The NN NN O
patient NN NN O
also NN NN O
reports NN NN O
occasional NNP NNP B-PROBLEM
numbness NNP NNP I-PROBLEM
and NN NN O
tingling NNP NNP B-PROBLEM
of NNP NNP I-PROBLEM
her NNP NNP I-PROBLEM
left NNP NNP I-PROBLEM
arm NNP NNP I-PROBLEM
. NN NN O

PHYSICAL NN NN O
EXAMINATION NN NN O
VITAL NN NN O
SIGNS NN NN O
: NN NN O
Blood NNP NNP B-TEST
pressure NNP NNP I-TEST
123/95 NN NN O
, NN NN O
heart NNP NNP B-TEST
rate NNP NNP I-TEST
83 NN NN O
, NN NN O
respirations NNP NNP B-TEST
20 NN NN O
, NN NN O
temperature NNP NNP B-TEST
97 NN NN O
, NN NN O
and NN NN O
oxygen NNP NNP B-TEST
saturation NNP NNP I-TEST
97% NN NN O
. NN NN O

GENERAL NN NN O
: NN NN O
Positive NN NN O
nonproductive NNP NNP B-PROBLEM
cough NNP NNP I-PROBLEM
and NN NN O
pain NNP NNP B-PROBLEM
with NN NN O
coughing NNP NNP B-PROBLEM
. NN NN O

HEENT NN NN O
: NN NN O
Pupils NN NN O
are NN NN O
equal NN NN O
and NN NN O
reactive NN NN O
to NN NN O
light NN NN O
and NN NN O
accommodation NN NN O
. NN NN O

Tympanic NN NN O
membranes NN NN O
are NN NN O
clear NN NN O
. NN NN O

NECK NN NN O
: NN NN O
Supple NN NN O
. NN NN O

No NN NN O
lymphadenopathy NNP NNP B-PROBLEM
. NN NN O

No NN NN O
masses NNP NNP B-PROBLEM
. NN NN O

RESPIRATORY NN NN O
: NN NN O
Pleural NNP NNP B-PROBLEM
friction NNP NNP I-PROBLEM
rub NNP NNP I-PROBLEM
is NN NN O
noted NN NN O
. NN NN O

GI NN NN O
: NN NN O
Soft NN NN O
, NN NN O
nondistended NNP NNP B-PROBLEM
, NN NN O
and NN NN O
nontender NNP NNP B-PROBLEM
. NN NN O

Positive NN NN O
bowel NN NN O
sounds NN NN O
. NN NN O

No NN NN O
organomegaly NNP NNP B-PROBLEM
. NN NN O

EXTREMITIES NN NN O
: NN NN O
No NN NN O
edema NNP NNP B-PROBLEM
, NN NN O
no NN NN O
clubbing NNP NNP B-PROBLEM
, NN NN O
no NN NN O
cyanosis NNP NNP B-PROBLEM
, NN NN O
no NN NN O
tenderness NNP NNP B-PROBLEM
. NN NN O

Full NN NN O
range NN NN O
of NN NN O
motion NN NN O
. NN NN O

Normal NN NN O
pulses NN NN O
in NN NN O
all NN NN O
extremities NN NN O
. NN NN O

SKIN NN NN O
: NN NN O
No NN NN O
breakdown NNP NNP B-PROBLEM
or NN NN O
lesions NNP NNP B-PROBLEM
. NN NN O

No NN NN O
ulcers NNP NNP B-PROBLEM
. NN NN O

NEUROLOGIC NN NN O
: NN NN O
Grossly NN NN O
intact NN NN O
. NN NN O

No NN NN O
focal NNP NNP B-PROBLEM
deficits NNP NNP I-PROBLEM
. NN NN O

Awake NN NN O
, NN NN O
alert NN NN O
, NN NN O
and NN NN O
oriented NN NN O
to NN NN O
person NN NN O
, NN NN O
place NN NN O
, NN NN O
and NN NN O
time NN NN O
. NN NN O

LABORATORY NN NN O
DATA NN NN O
: NN NN O
Labs NNP NNP B-TEST
are NN NN O
pending NN NN O
. NN NN O

HOSPITAL NN NN O
COURSE NN NN O
: NN NN O
The NN NN O
patient NN NN O
was NN NN O
admitted NN NN O
for NN NN O
a NNP NNP B-PROBLEM
right-sided NNP NNP I-PROBLEM
pleural NNP NNP I-PROBLEM
effusion NNP NNP I-PROBLEM
for NN NN O
thoracentesis NNP NNP B-TREATMENT
on NN NN O
Monday NNP NNP B-DATE
by NN NN O
Dr NN NN O
. NN NN O
X NN NN O
. NN NN O
Her NNP NNP B-TREATMENT
Coumadin NNP NNP I-TREATMENT
was NN NN O
placed NN NN O
on NN NN O
hold NN NN O
. NN NN O

A NNP NNP B-TEST
repeat NNP NNP I-TEST
echocardiogram NNP NNP I-TEST
was NN NN O
checked NN NN O
. NN NN O

She NN NN O
was NN NN O
started NN NN O
on NN NN O
prophylaxis NNP NNP B-TREATMENT
for NN NN O
DVT NNP NNP B-PROBLEM
with NN NN O
Lovenox NNP NNP B-TREATMENT
40 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
subcutaneously NNP NNP B-ROUTE
. NN NN O

Her NN NN O
history NN NN O
dated NN NN O
back NN NN O
to NN NN O
March NNP NNP B-DATE
2005 NNP NNP I-DATE
when NN NN O
she NN NN O
first NN NN O
sought NN NN O
medical NN NN O
attention NN NN O
for NN NN O
evidence NN NN O
of NN NN O
pericarditis NNP NNP B-PROBLEM
, NN NN O
which NN NN O
was NN NN O
treated NN NN O
with NN NN O
pericardial NNP NNP B-TREATMENT
window NNP NNP I-TREATMENT
in NN NN O
an NN NN O
outside NN NN O
hospital NN NN O
, NN NN O
at NN NN O
that NN NN O
time NN NN O
she NN NN O
was NN NN O
also NN NN O
found NN NN O
to NN NN O
have NN NN O
mesenteric NNP NNP B-PROBLEM
pain NNP NNP I-PROBLEM
and NN NN O
thrombosis NNP NNP B-PROBLEM
, NN NN O
is NN NN O
now NN NN O
anticoagulated NNP NNP B-TREATMENT
. NN NN O

Her NN NN O
pericardial NN NN O
fluid NN NN O
was NN NN O
accumulated NN NN O
and NN NN O
she NN NN O
was NN NN O
seen NN NN O
by NN NN O
Dr NN NN O
. NN NN O
Y NNP NNP B-NAME
. NN NN O

At NN NN O
that NN NN O
time NN NN O
, NN NN O
she NN NN O
was NN NN O
recommended NN NN O
for NN NN O
pericardectomy NNP NNP B-TREATMENT
, NN NN O
which NN NN O
was NN NN O
performed NN NN O
by NN NN O
Dr NN NN O
. NN NN O
Z NNP NNP B-NAME
. NN NN O

Review NN NN O
of NN NN O
her NNP NNP B-TEST
CT NNP NNP I-TEST
scan NNP NNP I-TEST
from NN NN O
March NNP NNP B-DATE
2006 NNP NNP I-DATE
prior NN NN O
to NN NN O
her NNP NNP B-TREATMENT
pericardectomy NNP NNP I-TREATMENT
, NN NN O
already NN NN O
shows NN NN O
bilateral NNP NNP B-PROBLEM
plural NNP NNP I-PROBLEM
effusions NNP NNP I-PROBLEM
. NN NN O

The NN NN O
patient NN NN O
improved NN NN O
clinically NN NN O
after NN NN O
the NNP NNP B-TREATMENT
pericardectomy NNP NNP I-TREATMENT
with NN NN O
resolution NN NN O
of NN NN O
her NNP NNP B-PROBLEM
symptoms NNP NNP I-PROBLEM
. NN NN O

Recently NN NN O
, NN NN O
she NN NN O
was NN NN O
readmitted NN NN O
to NN NN O
the NN NN O
hospital NN NN O
with NN NN O
chest NNP NNP B-PROBLEM
pain NNP NNP I-PROBLEM
and NN NN O
found NN NN O
to NN NN O
have NN NN O
bilateral NNP NNP B-PROBLEM
pleural NNP NNP I-PROBLEM
effusion NNP NNP I-PROBLEM
, NN NN O
the NN NN O
right NN NN O
greater NN NN O
than NN NN O
the NN NN O
left NN NN O
. NN NN O

CT NNP NNP B-TEST
of NNP NNP I-TEST
the NNP NNP I-TEST
chest NNP NNP I-TEST
also NN NN O
revealed NN NN O
a NNP NNP B-PROBLEM
large NNP NNP I-PROBLEM
mediastinal NNP NNP I-PROBLEM
lymph NNP NNP I-PROBLEM
node NNP NNP I-PROBLEM
. NN NN O

We NN NN O
reviewed NN NN O
the NNP NNP B-TEST
pathology NNP NNP I-TEST
obtained NN NN O
from NN NN O
the NNP NNP B-TREATMENT
pericardectomy NNP NNP I-TREATMENT
in NN NN O
March NNP NNP B-DATE
2006 NNP NNP I-DATE
, NN NN O
which NN NN O
was NN NN O
diagnostic NN NN O
of NN NN O
mesothelioma NNP NNP B-PROBLEM
. NN NN O

At NN NN O
this NN NN O
time NN NN O
, NN NN O
chest NNP NNP B-TREATMENT
tube NNP NNP I-TREATMENT
placement NNP NNP I-TREATMENT
for NN NN O
drainage NNP NNP B-PROBLEM
of NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
fluid NNP NNP I-PROBLEM
occurred NN NN O
and NN NN O
thoracoscopy NNP NNP B-TREATMENT
with NN NN O
fluid NNP NNP B-TEST
biopsies NNP NNP I-TEST
, NN NN O
which NN NN O
were NN NN O
performed NN NN O
, NN NN O
which NN NN O
revealed NN NN O
epithelioid NNP NNP B-PROBLEM
malignant NNP NNP I-PROBLEM
mesothelioma NNP NNP I-PROBLEM
. NN NN O

The NN NN O
patient NN NN O
was NN NN O
then NN NN O
stained NN NN O
with NN NN O
a NNP NNP B-TEST
PET NNP NNP I-TEST
CT NNP NNP I-TEST
, NN NN O
which NN NN O
showed NN NN O
extensive NNP NNP B-PROBLEM
uptake NNP NNP I-PROBLEM
in NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
chest NNP NNP I-PROBLEM
, NN NN O
bilateral NNP NNP B-PROBLEM
pleural NNP NNP I-PROBLEM
pericardial NNP NNP I-PROBLEM
effusions NNP NNP I-PROBLEM
, NN NN O
and NN NN O
lymphadenopathy NNP NNP B-PROBLEM
. NN NN O

She NN NN O
also NN NN O
had NN NN O
acidic NNP NNP B-PROBLEM
fluid NNP NNP I-PROBLEM
, NN NN O
pectoral NNP NNP B-PROBLEM
and NNP NNP I-PROBLEM
intramammary NNP NNP I-PROBLEM
lymph NNP NNP I-PROBLEM
nodes NNP NNP I-PROBLEM
and NN NN O
uptake NNP NNP B-PROBLEM
in NNP NNP I-PROBLEM
L4 NNP NNP I-PROBLEM
with NN NN O
SUV NNP NNP B-TEST
of NN NN O

4 NN NN O
. NN NN O
This NN NN O
was NN NN O
consistent NN NN O
with NN NN O
stage NNP NNP B-PROBLEM
III NNP NNP I-PROBLEM
disease NNP NNP I-PROBLEM
. NN NN O

Her NNP NNP B-TEST
repeat NNP NNP I-TEST
echocardiogram NNP NNP I-TEST
showed NN NN O
an NNP NNP B-TEST
ejection NNP NNP I-TEST
fraction NNP NNP I-TEST
of NN NN O
45% NN NN O
to NN NN O
49% NN NN O
. NN NN O

She NN NN O
was NN NN O
transferred NN NN O
to NN NN O
Oncology NN NN O
service NN NN O
and NN NN O
started NN NN O
on NN NN O
chemotherapy NNP NNP B-TREATMENT
on NN NN O
September NNP NNP B-DATE
1 NNP NNP I-DATE
, NNP NNP I-DATE
2007 NNP NNP I-DATE
with NN NN O
cisplatin NNP NNP B-TREATMENT
75 NNP NNP B-STRENGTH
mg/centimeter NNP NNP I-STRENGTH
squared NN NN O
equaling NN NN O
109 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
IV NNP NNP B-TREATMENT
piggyback NNP NNP I-TREATMENT
over NNP NNP B-DURATION
2 NNP NNP I-DURATION
hours NNP NNP I-DURATION
on NN NN O
September NNP NNP B-DATE
1 NNP NNP I-DATE
, NNP NNP I-DATE
2007 NNP NNP I-DATE
, NN NN O
Alimta NNP NNP B-TREATMENT
500 NNP NNP B-STRENGTH
mg/ NNP NNP I-STRENGTH
centimeter NNP NNP B-FORM
squared NNP NNP I-FORM
equaling NN NN O
730 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
IV NNP NNP B-TREATMENT
piggyback NNP NNP I-TREATMENT
over NNP NNP B-DURATION
10 NNP NNP I-DURATION
minutes NNP NNP I-DURATION
. NN NN O

This NN NN O
was NN NN O
all NN NN O
initiated NN NN O
after NN NN O
a NNP NNP B-TREATMENT
Port-A-Cath NNP NNP I-TREATMENT
was NN NN O
placed NN NN O
. NN NN O

The NNP NNP B-TREATMENT
chemotherapy NNP NNP I-TREATMENT
was NN NN O
well NN NN O
tolerated NN NN O
and NN NN O
the NN NN O
patient NN NN O
was NN NN O
discharged NN NN O
the NN NN O
following NN NN O
day NN NN O
after NN NN O
discontinuing NN NN O
IV NNP NNP B-TREATMENT
fluid NNP NNP I-TREATMENT
and NN NN O
IV NNP NNP B-TREATMENT
. NN NN O

Her NNP NNP B-TREATMENT
Port-A-Cath NNP NNP I-TREATMENT
was NN NN O
packed NN NN O
with NN NN O
heparin NNP NNP B-TREATMENT
according NN NN O
to NN NN O
protocol NN NN O
. NN NN O

DISCHARGE NNP NNP B-TREATMENT
MEDICATIONS NNP NNP I-TREATMENT
: NN NN O
Zofran NNP NNP B-TREATMENT
, NN NN O
Phenergan NNP NNP B-TREATMENT
, NN NN O
Coumadin NNP NNP B-TREATMENT
, NN NN O
and NN NN O
Lovenox NNP NNP B-TREATMENT
, NN NN O
and NN NN O
Vicodin NNP NNP B-TREATMENT
DISCHARGE NN NN O
INSTRUCTIONS NN NN O
: NN NN O
She NN NN O
was NN NN O
instructed NN NN O
to NN NN O
followup NN NN O
with NN NN O
Dr NN NN O
. NN NN O
XYZ NNP NNP B-NAME
in NN NN O
the NN NN O
office NN NN O
to NN NN O
check NN NN O
her NNP NNP B-TEST
INR NNP NNP I-TEST
on NN NN O
Tuesday NNP NNP B-DATE
. NN NN O

She NN NN O
was NN NN O
instructed NN NN O
to NN NN O
call NN NN O
if NN NN O
she NN NN O
had NN NN O
any NN NN O
other NN NN O
questions NN NN O
or NN NN O
concerns NN NN O
in NN NN O
the NN NN O
interim NN NN O
. NN NN O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Axillary NNP NNP B-TREATMENT
Dissection NNP NNP I-TREATMENT
& NNP NNP I-TREATMENT
Mass NNP NNP I-TREATMENT
Excision NNP NNP I-TREATMENT
Description NN NN O
: NN NN O
Left NNP NNP B-TREATMENT
axillary NNP NNP I-TREATMENT
dissection NNP NNP I-TREATMENT
with NN NN O
incision NNP NNP B-PROBLEM
and NN NN O
drainage NNP NNP B-TREATMENT
of NN NN O
left NNP NNP B-PROBLEM
axillary NNP NNP I-PROBLEM
mass NNP NNP I-PROBLEM
. NN NN O

Right NNP NNP B-TREATMENT
axillary NNP NNP I-TREATMENT
mass NNP NNP I-TREATMENT
excision NNP NNP I-TREATMENT
and NN NN O
incision NNP NNP B-PROBLEM
and NN NN O
drainage NNP NNP B-TREATMENT
. NN NN O

Bilateral NNP NNP B-PROBLEM
axillary NNP NNP I-PROBLEM
masses NNP NNP I-PROBLEM
, NN NN O
rule NN NN O
out NN NN O
recurrent NNP NNP B-PROBLEM
Hodgkin's NNP NNP I-PROBLEM
disease NNP NNP I-PROBLEM
. NN NN O

( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
PREOPERATIVE NN NN O
DIAGNOSIS NN NN O
: NN NN O
Bilateral NNP NNP B-PROBLEM
axillary NNP NNP I-PROBLEM
masses NNP NNP I-PROBLEM
, NN NN O
rule NN NN O
out NN NN O
recurrent NNP NNP B-PROBLEM
Hodgkin's NNP NNP I-PROBLEM
disease NNP NNP I-PROBLEM
. NN NN O

POSTOPERATIVE NN NN O
DIAGNOSIS NN NN O
: NN NN O
Bilateral NNP NNP B-PROBLEM
axillary NNP NNP I-PROBLEM
masses NNP NNP I-PROBLEM
, NN NN O
rule NN NN O
out NN NN O
recurrent NNP NNP B-PROBLEM
Hodgkin's NNP NNP I-PROBLEM
disease NNP NNP I-PROBLEM
. NN NN O

PROCEDURE NN NN O
PERFORMED NN NN O
: NN NN O

1 NN NN O
. NN NN O
Left NNP NNP B-TREATMENT
axillary NNP NNP I-TREATMENT
dissection NNP NNP I-TREATMENT
with NN NN O
incision NNP NNP B-PROBLEM
and NN NN O
drainage NNP NNP B-TREATMENT
of NN NN O
left NNP NNP B-PROBLEM
axillary NNP NNP I-PROBLEM
mass NNP NNP I-PROBLEM
. NN NN O

2 NN NN O
. NN NN O
Right NNP NNP B-TREATMENT
axillary NNP NNP I-TREATMENT
mass NNP NNP I-TREATMENT
excision NNP NNP I-TREATMENT
and NN NN O
incision NNP NNP B-PROBLEM
and NN NN O
drainage NNP NNP B-TREATMENT
. NN NN O

ANESTHESIA NN NN O
: NN NN O
LMA NNP NNP B-TREATMENT
. NN NN O

SPECIMENS NN NN O
: NN NN O
Left NNP NNP B-PROBLEM
axillary NNP NNP I-PROBLEM
mass NNP NNP I-PROBLEM
with NN NN O
nodes NNP NNP B-PROBLEM
and NN NN O
right NNP NNP B-PROBLEM
axillary NNP NNP I-PROBLEM
mass NNP NNP I-PROBLEM
. NN NN O

ESTIMATED NN NN O
BLOOD NN NN O
LOSS NN NN O
: NN NN O
Less NN NN O
than NN NN O
30 NN NN O
cc NN NN O
. NN NN O

INDICATION NN NN O
: NN NN O
This NN NN O
56-year-old NNP NNP B-AGE
male NN NN O
presents NN NN O
to NN NN O
surgical NN NN O
office NN NN O
with NN NN O
history NN NN O
of NN NN O
bilateral NNP NNP B-PROBLEM
axillary NNP NNP I-PROBLEM
masses NNP NNP I-PROBLEM
. NN NN O

Upon NN NN O
evaluation NNP NNP B-TEST
, NN NN O
it NN NN O
was NN NN O
noted NN NN O
that NN NN O
the NN NN O
patient NN NN O
has NN NN O
draining NNP NNP B-PROBLEM
bilateral NNP NNP I-PROBLEM
masses NNP NNP I-PROBLEM
with NN NN O
the NNP NNP B-PROBLEM
left NNP NNP I-PROBLEM
mass NNP NNP I-PROBLEM
being NN NN O
approximately NN NN O
8 NN NN O
cm NN NN O
in NN NN O
diameter NN NN O
upon NN NN O
palpation NNP NNP B-TEST
and NN NN O
the NN NN O
right NN NN O
being NN NN O
approximately NN NN O
4 NN NN O
cm NN NN O
in NN NN O
diameter NN NN O
. NN NN O

The NN NN O
patient NN NN O
had NN NN O
been NN NN O
continued NN NN O
on NN NN O
antibiotics NNP NNP B-TREATMENT
preoperatively NN NN O
. NN NN O

The NN NN O
patient NN NN O
with NN NN O
history NN NN O
of NN NN O
Hodgkin's NNP NNP B-PROBLEM
lymphoma NNP NNP I-PROBLEM
approximately NN NN O
18 NN NN O
years NN NN O
ago NN NN O
and NN NN O
underwent NN NN O
therapy NNP NNP B-TREATMENT
at NN NN O
that NN NN O
time NN NN O
and NN NN O
he NN NN O
was NN NN O
declared NN NN O
free NN NN O
of NN NN O
disease NNP NNP B-PROBLEM
since NN NN O
that NN NN O
time NN NN O
. NN NN O

Consent NN NN O
for NN NN O
possible NN NN O
recurrence NNP NNP B-PROBLEM
of NN NN O
Hodgkin's NNP NNP B-PROBLEM
lymphoma NNP NNP I-PROBLEM
warranted NN NN O
exploration NNP NNP B-TEST
and NN NN O
excision NNP NNP B-TREATMENT
of NN NN O
these NNP NNP B-PROBLEM
masses NNP NNP I-PROBLEM
. NN NN O

The NN NN O
patient NN NN O
was NN NN O
explained NN NN O
the NN NN O
risks NN NN O
and NN NN O
benefits NN NN O
of NN NN O
the NNP NNP B-TREATMENT
procedure NNP NNP I-TREATMENT
and NN NN O
informed NN NN O
consent NN NN O
was NN NN O
obtained NN NN O
. NN NN O

GROSS NN NN O
FINDINGS NN NN O
: NN NN O
Upon NN NN O
dissection NNP NNP B-TREATMENT
of NN NN O
the NNP NNP B-PROBLEM
left NNP NNP I-PROBLEM
axillary NNP NNP I-PROBLEM
mass NNP NNP I-PROBLEM
, NN NN O
the NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
was NN NN O
removed NN NN O
in NN NN O
toto NN NN O
and NN NN O
noted NN NN O
to NN NN O
have NN NN O
a NN NN O
cavity NN NN O
within NN NN O
it NN NN O
consistent NN NN O
with NN NN O
an NNP NNP B-PROBLEM
abscess NNP NNP I-PROBLEM
. NN NN O

No NN NN O
loose NNP NNP B-PROBLEM
structures NNP NNP I-PROBLEM
were NN NN O
identified NN NN O
and NN NN O
sent NN NN O
for NN NN O
frozen NNP NNP B-TEST
section NNP NNP I-TEST
, NN NN O
which NN NN O
upon NN NN O
intraoperative NN NN O
consultation NN NN O
with NN NN O
Pathology NN NN O
Department NN NN O
revealed NN NN O
no NN NN O
obvious NN NN O
evidence NN NN O
of NN NN O
lymphoma NNP NNP B-PROBLEM
, NN NN O
however NN NN O
, NN NN O
the NN NN O
confirmed NN NN O
pathology NN NN O
report NN NN O
is NN NN O
pending NN NN O
at NN NN O
this NN NN O
time NN NN O
. NN NN O

The NNP NNP B-PROBLEM
right NNP NNP I-PROBLEM
axillary NNP NNP I-PROBLEM
mass NNP NNP I-PROBLEM
was NN NN O
excised NNP NNP B-TREATMENT
without NN NN O
difficulty NN NN O
without NN NN O
requiring NN NN O
full NNP NNP B-TREATMENT
axillary NNP NNP I-TREATMENT
dissection NNP NNP I-TREATMENT
. NN NN O

PROCEDURE NN NN O
: NN NN O
The NN NN O
patient NN NN O
was NN NN O
placed NN NN O
in NN NN O
supine NN NN O
position NN NN O
after NN NN O
appropriate NNP NNP B-TREATMENT
anesthesia NNP NNP I-TREATMENT
was NN NN O
obtained NN NN O
and NN NN O
a NNP NNP B-TREATMENT
sterile NNP NNP I-TREATMENT
prep NNP NNP I-TREATMENT
and NN NN O
drape NNP NNP B-TREATMENT
complete NN NN O
. NN NN O

A NNP NNP B-TREATMENT
#10 NNP NNP I-TREATMENT
blade NNP NNP I-TREATMENT
scalpel NNP NNP I-TREATMENT
was NN NN O
used NN NN O
to NN NN O
make NN NN O
an NNP NNP B-PROBLEM
elliptical NNP NNP I-PROBLEM
incision NNP NNP I-PROBLEM
about NN NN O
the NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
itself NN NN O
extending NN NN O
this NNP NNP B-PROBLEM
incision NNP NNP I-PROBLEM
further NN NN O
to NN NN O
aid NN NN O
in NN NN O
the NN NN O
mobilization NN NN O
of NN NN O
the NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
. NN NN O

Sharp NNP NNP B-TREATMENT
dissection NNP NNP I-TREATMENT
was NN NN O
utilized NN NN O
with NN NN O
Metzenbaum NNP NNP B-TREATMENT
scissors NNP NNP I-TREATMENT
about NN NN O
the NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
to NN NN O
maintain NN NN O
the NNP NNP B-PROBLEM
injury NNP NNP I-PROBLEM
to NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
skin NNP NNP I-PROBLEM
structure NNP NNP I-PROBLEM
and NN NN O
upon NN NN O
showing NN NN O
out NN NN O
the NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
, NN NN O
Bovie NNP NNP B-TREATMENT
electrocautery NNP NNP I-TREATMENT
was NN NN O
utilized NN NN O
adjacent NN NN O
to NN NN O
the NN NN O
wall NN NN O
structure NN NN O
to NN NN O
maintain NN NN O
hemostasis NNP NNP B-TEST
. NN NN O

Identification NN NN O
of NN NN O
the NN NN O
axillary NN NN O
anatomy NN NN O
was NN NN O
made NN NN O
and NN NN O
care NN NN O
was NN NN O
made NN NN O
to NN NN O
avoid NN NN O
injury NNP NNP B-PROBLEM
to NNP NNP I-PROBLEM
nerve NNP NNP I-PROBLEM
, NNP NNP I-PROBLEM
vessel NNP NNP I-PROBLEM
or NNP NNP I-PROBLEM
musculature NNP NNP I-PROBLEM
. NN NN O

Once NN NN O
this NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
was NN NN O
removed NN NN O
in NN NN O
toto NN NN O
, NN NN O
lymph NN NN O
node NN NN O
structures NN NN O
were NN NN O
as NN NN O
well NN NN O
delivered NN NN O
with NN NN O
this NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
and NN NN O
sent NN NN O
to NN NN O
frozen NNP NNP B-TEST
section NNP NNP I-TEST
as NN NN O
well NN NN O
the NNP NNP B-TEST
specimen NNP NNP I-TEST
was NN NN O
sent NN NN O
to NN NN O
gram NNP NNP B-TEST
stain NNP NNP I-TEST
and NN NN O
culture NNP NNP B-TEST
. NN NN O

Upon NN NN O
revaluation NNP NNP B-TEST
of NN NN O
the NNP NNP B-PROBLEM
incisional NNP NNP I-PROBLEM
site NNP NNP I-PROBLEM
, NN NN O
it NN NN O
was NN NN O
noted NN NN O
to NN NN O
be NN NN O
hemostatic NN NN O
. NN NN O

Warm NNP NNP B-TREATMENT
lap NNP NNP I-TREATMENT
sponge NNP NNP I-TREATMENT
was NN NN O
then NN NN O
left NN NN O
in NN NN O
place NN NN O
at NN NN O
this NN NN O
site NN NN O
. NN NN O

Next NN NN O
, NN NN O
attention NN NN O
was NN NN O
turned NN NN O
to NN NN O
the NN NN O
right NN NN O
axilla NN NN O
where NN NN O
a NNP NNP B-TREATMENT
#10 NNP NNP I-TREATMENT
blade NNP NNP I-TREATMENT
scalpel NNP NNP I-TREATMENT
was NN NN O
used NN NN O
to NN NN O
make NN NN O
a NNP NNP B-PROBLEM
4 NNP NNP I-PROBLEM
cm NNP NNP I-PROBLEM
incision NNP NNP I-PROBLEM
about NN NN O
the NNP NNP B-PROBLEM
mass NNP NNP I-PROBLEM
including NN NN O
the NNP NNP B-PROBLEM
cutaneous NNP NNP I-PROBLEM
structures NNP NNP I-PROBLEM
involved NN NN O
with NN NN O
the NNP NNP B-PROBLEM
erythematous NNP NNP I-PROBLEM
reaction NNP NNP I-PROBLEM
. NN NN O

This NN NN O
was NN NN O
as NN NN O
well NN NN O
removed NN NN O
in NN NN O
toto NN NN O
and NN NN O
sent NN NN O
to NN NN O
Pathology NN NN O
for NN NN O
gram NNP NNP B-TEST
stain NNP NNP I-TEST
and NN NN O
culture NNP NNP B-TEST
as NN NN O
well NN NN O
as NN NN O
pathologic NNP NNP B-TEST
evaluation NNP NNP I-TEST
. NN NN O

This NN NN O
site NN NN O
was NN NN O
then NN NN O
made NN NN O
hemostatic NN NN O
as NN NN O
well NN NN O
with NN NN O
the NN NN O
aid NN NN O
of NN NN O
Bovie NNP NNP B-TREATMENT
electrocautery NNP NNP I-TREATMENT
and NN NN O
approximation NNP NNP B-TREATMENT
of NNP NNP I-TREATMENT
the NNP NNP I-TREATMENT
deep NNP NNP I-TREATMENT
dermal NNP NNP I-TREATMENT
tissues NNP NNP I-TREATMENT
after NN NN O
irrigation NNP NNP B-TREATMENT
with NN NN O
warm NNP NNP B-TREATMENT
saline NNP NNP I-TREATMENT
was NN NN O
then NN NN O
done NN NN O
with NN NN O
#3-0 NNP NNP B-TREATMENT
Vicryl NNP NNP I-TREATMENT
suture NNP NNP I-TREATMENT
followed NN NN O
by NN NN O
#4-0 NN NN O
Vicryl NNP NNP B-TREATMENT
running NN NN O
subcuticular NNP NNP B-TREATMENT
stitch NNP NNP I-TREATMENT
. NN NN O

Steri-Strips NNP NNP B-TREATMENT
were NN NN O
applied NN NN O
. NN NN O

Attention NN NN O
was NN NN O
returned NN NN O
back NN NN O
left NN NN O
axilla NN NN O
, NN NN O
which NN NN O
upon NN NN O
re-exploration NNP NNP B-TEST
was NN NN O
noted NN NN O
to NN NN O
be NN NN O
hemostatic NN NN O
and NN NN O
a NNP NNP B-TREATMENT
#7 NNP NNP I-TREATMENT
mm NNP NNP I-TREATMENT
JP NNP NNP I-TREATMENT
was NN NN O
then NN NN O
introduced NN NN O
making NN NN O
a NNP NNP B-PROBLEM
skin NNP NNP I-PROBLEM
stab NNP NNP I-PROBLEM
inferior NN NN O
to NN NN O
the NNP NNP B-PROBLEM
incision NNP NNP I-PROBLEM
and NN NN O
bringing NN NN O
the NN NN O
end NN NN O
of NN NN O
the NNP NNP B-TREATMENT
drain NNP NNP I-TREATMENT
through NN NN O
this NNP NNP B-PROBLEM
incision NNP NNP I-PROBLEM
. NN NN O

This NN NN O
was NN NN O
placed NN NN O
within NN NN O
the NNP NNP B-PROBLEM
incision NNP NNP I-PROBLEM
site NNP NNP I-PROBLEM
, NN NN O
________ NN NN O
drainage NNP NNP B-PROBLEM
of NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
axillary NNP NNP I-PROBLEM
potential NNP NNP I-PROBLEM
space NNP NNP I-PROBLEM
. NN NN O

Approximation NNP NNP B-TREATMENT
of NNP NNP I-TREATMENT
the NNP NNP I-TREATMENT
deep NNP NNP I-TREATMENT
dermal NNP NNP I-TREATMENT
tissues NNP NNP I-TREATMENT
were NN NN O
then NN NN O
done NN NN O
with NN NN O
#3-0 NNP NNP B-TREATMENT
Vicryl NNP NNP I-TREATMENT
in NN NN O
an NN NN O
interrupted NN NN O
technique NN NN O
followed NN NN O
by NN NN O
#4-0 NN NN O
Vicryl NNP NNP B-TREATMENT
with NN NN O
running NN NN O
subcuticular NN NN O
technique NN NN O
. NN NN O

Steri-Strips NNP NNP B-TREATMENT
and NN NN O
sterile NNP NNP B-TREATMENT
dressings NNP NNP I-TREATMENT
were NN NN O
applied NN NN O
. NN NN O

JP NNP NNP B-TREATMENT
bulb NNP NNP I-TREATMENT
was NN NN O
then NN NN O
placed NN NN O
to NN NN O
suction NNP NNP B-TREATMENT
and NN NN O
sterile NNP NNP B-TREATMENT
dressings NNP NNP I-TREATMENT
were NN NN O
applied NN NN O
to NN NN O
both NN NN O
axilla NN NN O
. NN NN O

The NN NN O
patient NN NN O
tolerated NN NN O
the NNP NNP B-TREATMENT
procedure NNP NNP I-TREATMENT
well NN NN O
and NN NN O
sent NN NN O
to NN NN O
postanesthesia NN NN O
care NN NN O
unit NN NN O
in NN NN O
a NN NN O
stable NN NN O
condition NN NN O
. NN NN O

He NN NN O
will NN NN O
be NN NN O
discharged NN NN O
to NN NN O
home NN NN O
upon NN NN O
ability NN NN O
of NN NN O
the NN NN O
patient NN NN O
to NN NN O
have NN NN O
pain NNP NNP B-PROBLEM
tolerance NNP NNP I-PROBLEM
with NN NN O
Vicodin NNP NNP B-TREATMENT
1-2 NNP NNP B-DOSAGE
as NN NN O
needed NN NN O
every NN NN O
six NN NN O
hours NN NN O
for NN NN O
pain NNP NNP B-PROBLEM
and NN NN O
continue NN NN O
on NN NN O
Keflex NNP NNP B-TREATMENT
antibiotics NNP NNP I-TREATMENT
until NN NN O
gram NNP NNP B-TEST
stain NNP NNP I-TEST
culture NNP NNP I-TEST
proves NN NN O
otherwise NN NN O
. NN NN O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Hematology NN NN O
Consult NN NN O
Description NN NN O
: NN NN O
Leukocytosis NNP NNP B-PROBLEM
, NN NN O
acute NNP NNP B-PROBLEM
deep NNP NNP I-PROBLEM
venous NNP NNP I-PROBLEM
thrombosis NNP NNP I-PROBLEM
, NN NN O
right NN NN O
lower NN NN O
extremity NN NN O
with NN NN O
bilateral NNP NNP B-PROBLEM
pulmonary NNP NNP I-PROBLEM
embolism NNP NNP I-PROBLEM
, NN NN O
on NN NN O
intravenous NNP NNP B-TREATMENT
heparin NNP NNP I-TREATMENT
complicated NN NN O
with NN NN O
acute NNP NNP B-PROBLEM
renal NNP NNP I-PROBLEM
failure NNP NNP I-PROBLEM
for NN NN O
evaluation NNP NNP B-TEST
. NN NN O

( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
REASON NN NN O
FOR NN NN O
CONSULTATION NN NN O
: NN NN O
Acute NNP NNP B-PROBLEM
deep NNP NNP I-PROBLEM
venous NNP NNP I-PROBLEM
thrombosis NNP NNP I-PROBLEM
, NN NN O
right NN NN O
lower NN NN O
extremity NN NN O
with NN NN O
bilateral NNP NNP B-PROBLEM
pulmonary NNP NNP I-PROBLEM
embolism NNP NNP I-PROBLEM
, NN NN O
on NN NN O
intravenous NNP NNP B-TREATMENT
heparin NNP NNP I-TREATMENT
complicated NN NN O
with NN NN O
acute NNP NNP B-PROBLEM
renal NNP NNP I-PROBLEM
failure NNP NNP I-PROBLEM
for NN NN O
evaluation NNP NNP B-TEST
. NN NN O

HISTORY NN NN O
OF NN NN O
PRESENTING NN NN O
ILLNESS NN NN O
: NN NN O
Briefly NN NN O
, NN NN O
this NN NN O
is NN NN O
a NN NN O
36-year-old NNP NNP B-AGE
robust NN NN O
Caucasian NN NN O
gentleman NN NN O
with NN NN O
no NN NN O
significant NN NN O
past NN NN O
medical NN NN O
or NN NN O
surgical NN NN O
history NN NN O
, NN NN O
who NN NN O
works NN NN O
as NN NN O
a NN NN O
sales NNP NNP B-PROFESSION
representative NNP NNP I-PROFESSION
, NN NN O
doing NN NN O
a NN NN O
lot NN NN O
of NN NN O
traveling NN NN O
by NN NN O
plane NN NN O
and NN NN O
car NN NN O
and NN NN O
attending NN NN O
several NN NN O
sales NN NN O
shows NN NN O
, NN NN O
developed NN NN O
acute NNP NNP B-PROBLEM
shortness NNP NNP I-PROBLEM
of NNP NNP I-PROBLEM
breath NNP NNP I-PROBLEM
with NN NN O
an NN NN O
episode NN NN O
of NN NN O
syncope NNP NNP B-PROBLEM
this NN NN O
weekend NN NN O
and NN NN O
was NN NN O
brought NN NN O
in NN NN O
by NN NN O
paramedics NN NN O
to NN NN O
Hospital NN NN O
. NN NN O

A NNP NNP B-TEST
V/Q NNP NNP I-TEST
scan NNP NNP I-TEST
revealed NN NN O
multiple NNP NNP B-PROBLEM
pulmonary NNP NNP I-PROBLEM
perfusion NNP NNP I-PROBLEM
defects NNP NNP I-PROBLEM
consistent NN NN O
with NN NN O
high NNP NNP B-PROBLEM
probability NNP NNP I-PROBLEM
pulmonary NNP NNP I-PROBLEM
embolism NNP NNP I-PROBLEM
. NN NN O

A NNP NNP B-TEST
Doppler NNP NNP I-TEST
venous NNP NNP I-TEST
study NNP NNP I-TEST
of NNP NNP I-TEST
the NNP NNP I-TEST
lower NNP NNP I-TEST
extremity NNP NNP I-TEST
also NN NN O
revealed NN NN O
nonocclusive NNP NNP B-PROBLEM
right NNP NNP I-PROBLEM
popliteal NNP NNP I-PROBLEM
vein NNP NNP I-PROBLEM
thrombosis NNP NNP I-PROBLEM
. NN NN O

A NNP NNP B-TEST
CT NNP NNP I-TEST
of NNP NNP I-TEST
the NNP NNP I-TEST
abdomen NNP NNP I-TEST
and NNP NNP I-TEST
pelvis NNP NNP I-TEST
revealed NN NN O
normal-appearing NN NN O
liver NN NN O
, NN NN O
spleen NN NN O
, NN NN O
and NN NN O
pancreas NN NN O
; NN NN O

however NN NN O
, NN NN O
the NN NN O
right NN NN O
kidney NN NN O
appeared NN NN O
smaller NN NN O
compared NN NN O
to NN NN O
left NN NN O
and NN NN O
suggesting NN NN O
possibility NN NN O
of NN NN O
renal NNP NNP B-PROBLEM
infarct NNP NNP I-PROBLEM
. NN NN O

Renal NNP NNP B-TEST
function NNP NNP I-TEST
on NNP NNP I-TEST
admission NNP NNP I-TEST
was NN NN O
within NN NN O
normal NN NN O
range NN NN O
; NN NN O

however NN NN O
, NN NN O
serial NNP NNP B-TEST
renal NNP NNP I-TEST
function NNP NNP I-TEST
showed NN NN O
rapid NNP NNP B-PROBLEM
increase NNP NNP I-PROBLEM
in NNP NNP I-PROBLEM
creatinine NNP NNP I-PROBLEM
to NN NN O
5 NN NN O
today NN NN O
. NN NN O

He NN NN O
has NN NN O
been NN NN O
on NN NN O
intravenous NNP NNP B-TREATMENT
heparin NNP NNP I-TREATMENT
and NN NN O
hemodialysis NNP NNP B-TREATMENT
is NN NN O
being NN NN O
planned NN NN O
for NN NN O
tomorrow NN NN O
. NN NN O

Reviewing NN NN O
his NN NN O
history NN NN O
, NN NN O
there NN NN O
is NN NN O
no NN NN O
family NN NN O
members NN NN O
with NN NN O
hypercoagulable NNP NNP B-PROBLEM
state NNP NNP I-PROBLEM
or NN NN O
prior NN NN O
history NN NN O
of NN NN O
any NNP NNP B-PROBLEM
thrombotic NNP NNP I-PROBLEM
complication NNP NNP I-PROBLEM
. NN NN O

He NN NN O
denies NN NN O
any NNP NNP B-PROBLEM
recent NNP NNP I-PROBLEM
injury NNP NNP I-PROBLEM
to NNP NNP I-PROBLEM
his NNP NNP I-PROBLEM
lower NNP NNP I-PROBLEM
extremity NNP NNP I-PROBLEM
and NN NN O
in NN NN O
fact NN NN O
denied NN NN O
any NNP NNP B-PROBLEM
calf NNP NNP I-PROBLEM
pain NNP NNP I-PROBLEM
or NN NN O
swelling NNP NNP B-PROBLEM
. NN NN O

PAST NN NN O
MEDICAL NN NN O
AND NN NN O
SURGICAL NN NN O
HISTORY NN NN O
: NN NN O
Unremarkable NN NN O
. NN NN O

SOCIAL NN NN O
HISTORY NN NN O
: NN NN O
He NN NN O
is NN NN O
married NN NN O
and NN NN O
has NN NN O
1 NN NN O
son NN NN O
. NN NN O

He NN NN O
has NN NN O
a NN NN O
brother NN NN O
who NN NN O
is NN NN O
healthy NN NN O
. NN NN O

There NN NN O
is NN NN O
no NN NN O
history NN NN O
of NN NN O
tobacco NN NN O
use NN NN O
or NN NN O
alcohol NN NN O
use NN NN O
. NN NN O

FAMILY NN NN O
HISTORY NN NN O
: NN NN O
No NN NN O
family NN NN O
history NN NN O
of NN NN O
hypercoagulable NNP NNP B-PROBLEM
condition NNP NNP I-PROBLEM
. NN NN O

MEDICATIONS NN NN O
: NN NN O
Advil NNP NNP B-TREATMENT
p.r.n NNP NNP B-FREQUENCY
. NN NN O

ALLERGIES NN NN O
: NN NN O
NONE NN NN O
. NN NN O

REVIEW NN NN O
OF NN NN O
SYSTEMS NN NN O
: NN NN O
Essentially NN NN O
unremarkable NN NN O
except NN NN O
for NN NN O
sudden NNP NNP B-PROBLEM
onset NNP NNP I-PROBLEM
dyspnea NNP NNP I-PROBLEM
on NN NN O
easy NN NN O
exertion NN NN O
complicated NN NN O
with NN NN O
episode NN NN O
of NN NN O
syncope NNP NNP B-PROBLEM
. NN NN O

He NN NN O
denied NN NN O
any NNP NNP B-PROBLEM
hemoptysis NNP NNP I-PROBLEM
. NN NN O

He NN NN O
denied NN NN O
any NNP NNP B-PROBLEM
calf NNP NNP I-PROBLEM
swelling NNP NNP I-PROBLEM
or NN NN O
pain NNP NNP B-PROBLEM
. NN NN O

Lately NN NN O
, NN NN O
he NN NN O
has NN NN O
been NN NN O
traveling NN NN O
and NN NN O
has NN NN O
been NN NN O
sitting NN NN O
behind NN NN O
a NN NN O
desk NN NN O
for NN NN O
a NN NN O
long NN NN O
period NN NN O
of NN NN O
time NN NN O
. NN NN O

PHYSICAL NN NN O
EXAMINATION NN NN O
: NN NN O
GENERAL NN NN O
: NN NN O
He NN NN O
is NN NN O
a NN NN O
robust NN NN O
young NN NN O
gentleman NN NN O
, NN NN O
awake NN NN O
, NN NN O
alert NN NN O
, NN NN O
and NN NN O
hemodynamically NN NN O
stable NN NN O
. NN NN O

HEENT NN NN O
: NN NN O
Sclerae NNP NNP B-PROBLEM
anicteric NNP NNP I-PROBLEM
. NN NN O

Conjunctivae NN NN O
normal NN NN O
. NN NN O

Oropharynx NN NN O
normal NN NN O
. NN NN O

NECK NN NN O
: NN NN O
No NN NN O
adenopathy NNP NNP B-PROBLEM
or NN NN O
thyromegaly NNP NNP B-PROBLEM
. NN NN O

No NN NN O
jugular NNP NNP B-PROBLEM
venous NNP NNP I-PROBLEM
distention NNP NNP I-PROBLEM
. NN NN O

HEART NN NN O
: NN NN O
Regular NN NN O
. NN NN O

LUNGS NN NN O
: NN NN O
Bilateral NN NN O
air NN NN O
entry NN NN O
. NN NN O

ABDOMEN NN NN O
: NN NN O
Obese NNP NNP B-PROBLEM
and NN NN O
benign NN NN O
. NN NN O

EXTREMITIES NN NN O
: NN NN O
No NN NN O
calf NNP NNP B-PROBLEM
swelling NNP NNP I-PROBLEM
or NN NN O
calf NNP NNP B-PROBLEM
tenderness NNP NNP I-PROBLEM
appreciated NN NN O
. NN NN O

SKIN NN NN O
: NN NN O
No NN NN O
petechiae NNP NNP B-PROBLEM
or NN NN O
ecchymosis NNP NNP B-PROBLEM
. NN NN O

NEUROLOGIC NN NN O
: NN NN O
Nonfocal NN NN O
. NN NN O

LABORATORY NN NN O
FINDINGS NN NN O
: NN NN O
Blood NNP NNP B-TEST
count NNP NNP I-TEST
obtained NN NN O
showed NN NN O
a NNP NNP B-TEST
white NNP NNP I-TEST
count NNP NNP I-TEST
of NN NN O
16.8 NN NN O
, NN NN O
hemoglobin NNP NNP B-TEST
14.8 NN NN O
g NN NN O
percent NN NN O
, NN NN O
hematocrit NNP NNP B-TEST
44.6% NN NN O
, NN NN O
MCV NNP NNP B-TEST
94 NN NN O
, NN NN O
and NN NN O
platelet NNP NNP B-TEST
count NNP NNP I-TEST
209,000 NN NN O
. NN NN O

Liver NN NN O
profile NN NN O
normal NN NN O
. NN NN O

Thyroid NNP NNP B-TEST
study NNP NNP I-TEST
revealed NN NN O
a NNP NNP B-TEST
TSH NNP NNP I-TEST
of NN NN O
1.3 NN NN O
. NN NN O

Prothrombin NNP NNP B-TEST
time/INR NNP NNP I-TEST
1.5 NN NN O
, NN NN O
partial NNP NNP B-TEST
thromboplastin NNP NNP I-TEST
time NNP NNP I-TEST
78.6 NN NN O
seconds NN NN O
. NN NN O

Renal NN NN O
function NN NN O
, NN NN O
BUN NNP NNP B-TEST
44 NN NN O
and NN NN O
creatinine NNP NNP B-TEST
5.7 NN NN O
. NN NN O

Echocardiogram NNP NNP B-TEST
revealed NN NN O
left NNP NNP B-PROBLEM
ventricular NNP NNP I-PROBLEM
hypertrophy NNP NNP I-PROBLEM
with NN NN O
ejection NNP NNP B-TEST
fraction NNP NNP I-TEST
of NN NN O
65% NN NN O
, NN NN O
no NN NN O
intramural NNP NNP B-PROBLEM
thrombus NNP NNP I-PROBLEM
noted NN NN O
. NN NN O

IMPRESSION NN NN O
: NN NN O

1 NN NN O
. NN NN O
Bilateral NNP NNP B-PROBLEM
pulmonary NNP NNP I-PROBLEM
embolism NNP NNP I-PROBLEM
, NN NN O
most NN NN O
consistent NN NN O
with NN NN O
emboli NNP NNP B-PROBLEM
from NNP NNP I-PROBLEM
right NNP NNP I-PROBLEM
lower NNP NNP I-PROBLEM
extremity NNP NNP I-PROBLEM
, NN NN O
on NN NN O
intravenous NNP NNP B-TREATMENT
heparin NNP NNP I-TREATMENT
, NN NN O
rule NN NN O
out NN NN O
hereditary NNP NNP B-PROBLEM
hypercoagulable NNP NNP I-PROBLEM
state NNP NNP I-PROBLEM
. NN NN O

2 NN NN O
. NN NN O
Leukocytosis NNP NNP B-PROBLEM
, NN NN O
most NN NN O
likely NN NN O
leukemoid NNP NNP B-PROBLEM
reaction NNP NNP I-PROBLEM
secondary NN NN O
to NN NN O
acute NNP NNP B-PROBLEM
pulmonary NNP NNP I-PROBLEM
embolism/renal NNP NNP I-PROBLEM
infarction NNP NNP I-PROBLEM
, NN NN O
doubt NN NN O
presence NN NN O
of NN NN O
myeloproliferative NNP NNP B-PROBLEM
disorder NNP NNP I-PROBLEM
. NN NN O

3 NN NN O
. NN NN O
Acute NNP NNP B-PROBLEM
renal NNP NNP I-PROBLEM
failure NNP NNP I-PROBLEM
secondary NN NN O
to NN NN O
embolic NNP NNP B-PROBLEM
right NNP NNP I-PROBLEM
renal NNP NNP I-PROBLEM
infarction NNP NNP I-PROBLEM
. NN NN O

4 NN NN O
. NN NN O
Obesity NNP NNP B-PROBLEM
. NN NN O

PLAN NN NN O
: NN NN O
From NN NN O
hematologic NN NN O
standpoint NN NN O
, NN NN O
we NN NN O
will NN NN O
await NN NN O
hypercoagulable NNP NNP B-TEST
studies NNP NNP I-TEST
, NN NN O
which NN NN O
have NN NN O
all NN NN O
been NN NN O
sent NN NN O
on NN NN O
admission NN NN O
to NN NN O
see NN NN O
if NN NN O
a NNP NNP B-PROBLEM
hereditary NNP NNP I-PROBLEM
component NNP NNP I-PROBLEM
is NN NN O
at NN NN O
play NN NN O
. NN NN O

For NN NN O
now NN NN O
, NN NN O
we NN NN O
will NN NN O
continue NN NN O
intravenous NNP NNP B-TREATMENT
heparin NNP NNP I-TREATMENT
and NN NN O
subsequent NNP NNP B-TREATMENT
oral NNP NNP I-TREATMENT
anticoagulation NNP NNP I-TREATMENT
with NN NN O
Coumadin NNP NNP B-TREATMENT
. NN NN O

In NN NN O
view NN NN O
of NN NN O
worsening NNP NNP B-PROBLEM
renal NNP NNP I-PROBLEM
function NNP NNP I-PROBLEM
, NN NN O
may NN NN O
need NN NN O
temporary NNP NNP B-TREATMENT
hemodialysis NNP NNP I-TREATMENT
until NN NN O
renal NN NN O
function NN NN O
improves NN NN O
. NN NN O

I NN NN O
discussed NN NN O
at NN NN O
length NN NN O
with NN NN O
the NN NN O
patient's NN NN O
wife NN NN O
at NN NN O
the NN NN O
bedside NN NN O
. NN NN O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Mantle NNP NNP B-PROBLEM
Cell NNP NNP I-PROBLEM
Lymphoma NNP NNP I-PROBLEM
Description NN NN O
: NN NN O
A NN NN O
61-year-old NNP NNP B-AGE
white NN NN O
male NN NN O
with NN NN O
a NN NN O
diagnosis NN NN O
of NN NN O
mantle NNP NNP B-PROBLEM
cell NNP NNP I-PROBLEM
lymphoma NNP NNP I-PROBLEM
status NN NN O
post NN NN O
autologous NNP NNP B-TREATMENT
transplant NNP NNP I-TREATMENT
with NN NN O
BEAM NNP NNP B-TREATMENT
regimen NNP NNP I-TREATMENT
followed NN NN O
by NN NN O
relapse NNP NNP B-PROBLEM
. NN NN O

Allogeneic NNP NNP B-TREATMENT
peripheral NNP NNP I-TREATMENT
stem NNP NNP I-TREATMENT
cell NNP NNP I-TREATMENT
transplant NNP NNP I-TREATMENT
from NN NN O
match-related NN NN O
brother NN NN O
and NN NN O
the NN NN O
patient NN NN O
is NN NN O
53 NN NN O
months NN NN O
out NN NN O
from NN NN O
transplant NN NN O
. NN NN O

( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
PRINCIPAL NN NN O
DIAGNOSES NN NN O
: NN NN O

1 NN NN O
. NN NN O
A NN NN O
61-year-old NNP NNP B-AGE
white NN NN O
male NN NN O
with NN NN O
a NN NN O
diagnosis NN NN O
of NN NN O
mantle NNP NNP B-PROBLEM
cell NNP NNP I-PROBLEM
lymphoma NNP NNP I-PROBLEM
, NN NN O
diagnosed NN NN O
in NN NN O
2001 NNP NNP B-DATE
, NN NN O
status NN NN O
post NN NN O
autologous NNP NNP B-TREATMENT
transplant NNP NNP I-TREATMENT
with NN NN O
BEAM NNP NNP B-TREATMENT
regimen NNP NNP I-TREATMENT
in NN NN O
04/02 NNP NNP B-DATE
followed NN NN O
by NN NN O
relapse NNP NNP B-PROBLEM
. NN NN O

2 NN NN O
. NN NN O
Allogeneic NNP NNP B-TREATMENT
peripheral NNP NNP I-TREATMENT
stem NNP NNP I-TREATMENT
cell NNP NNP I-TREATMENT
transplant NNP NNP I-TREATMENT
from NN NN O
match-related NN NN O
brother NN NN O
and NN NN O
the NN NN O
patient NN NN O
is NN NN O
53 NN NN O
months NN NN O
out NN NN O
from NN NN O
transplant NN NN O
. NN NN O

3 NN NN O
. NN NN O
Graft NNP NNP B-PROBLEM
versus NNP NNP I-PROBLEM
host NNP NNP I-PROBLEM
disease NNP NNP I-PROBLEM
involving NN NN O
GI NN NN O
tracts NN NN O
, NN NN O
skin NN NN O
, NN NN O
and NN NN O
liver NN NN O
presently NN NN O
off NN NN O
immunosuppression NNP NNP B-TREATMENT
. NN NN O

4 NN NN O
. NN NN O
Diabetes NNP NNP B-PROBLEM
. NN NN O

5 NN NN O
. NN NN O
Bipolar NNP NNP B-PROBLEM
disorder NNP NNP I-PROBLEM
. NN NN O

6 NN NN O
. NN NN O
Chronic NNP NNP B-PROBLEM
muscle NNP NNP I-PROBLEM
aches NNP NNP I-PROBLEM
. NN NN O

7 NN NN O
. NN NN O
Chronic NNP NNP B-PROBLEM
lower NNP NNP I-PROBLEM
extremity NNP NNP I-PROBLEM
edema NNP NNP I-PROBLEM
. NN NN O

8 NN NN O
. NN NN O
ECOG NN NN O
performance NN NN O
status NN NN O

1 NN NN O
. NN NN O
INTERIM NN NN O
HISTORY NN NN O
: NN NN O
The NN NN O
patient NN NN O
comes NN NN O
to NN NN O
the NN NN O
clinic NN NN O
today NN NN O
for NN NN O
followup NN NN O
. NN NN O

I NN NN O
am NN NN O
seeing NN NN O
him NN NN O
once NN NN O
every NN NN O
4 NN NN O
to NN NN O
8 NN NN O
weeks NN NN O
. NN NN O

He NN NN O
is NN NN O
off NN NN O
of NN NN O
all NNP NNP B-TREATMENT
immunosuppression NNP NNP I-TREATMENT
. NN NN O

He NN NN O
does NN NN O
have NN NN O
mild NNP NNP B-PROBLEM
chronic NNP NNP I-PROBLEM
GVHD NNP NNP I-PROBLEM
but NN NN O
not NN NN O
enough NN NN O
to NN NN O
warrant NN NN O
any NNP NNP B-TREATMENT
therapy NNP NNP I-TREATMENT
and NN NN O
the NNP NNP B-PROBLEM
disease NNP NNP I-PROBLEM
has NN NN O
been NN NN O
under NN NN O
control NN NN O
and NN NN O
he NN NN O
is NN NN O
4-1/2-years NN NN O
posttransplant NN NN O
. NN NN O

He NN NN O
has NN NN O
multiple NN NN O
complaints NN NN O
. NN NN O

He NN NN O
has NN NN O
had NN NN O
hematochezia NNP NNP B-PROBLEM
. NN NN O

I NN NN O
referred NN NN O
him NN NN O
to NN NN O
gastroenterology NN NN O
. NN NN O

They NN NN O
did NN NN O
an NNP NNP B-TEST
upper NNP NNP I-TEST
and NNP NNP I-TEST
lower NNP NNP I-TEST
endoscopy NNP NNP I-TEST
. NN NN O

No NN NN O
evidence NN NN O
of NN NN O
ulcers NNP NNP B-PROBLEM
or NN NN O
any NNP NNP B-PROBLEM
abnormality NNP NNP I-PROBLEM
was NN NN O
found NN NN O
. NN NN O

Some NNP NNP B-PROBLEM
polyps NNP NNP I-PROBLEM
were NN NN O
removed NN NN O
. NN NN O

They NN NN O
were NN NN O
benign NN NN O
. NN NN O

He NN NN O
may NN NN O
have NN NN O
mild NNP NNP B-PROBLEM
iron NNP NNP I-PROBLEM
deficiency NNP NNP I-PROBLEM
, NN NN O
but NN NN O
he NN NN O
is NN NN O
fatigued NNP NNP B-PROBLEM
and NN NN O
has NN NN O
several NN NN O
complaints NN NN O
related NN NN O
to NN NN O
his NN NN O
level NN NN O
of NN NN O
activity NN NN O
. NN NN O

CURRENT NN NN O
MEDICATIONS NN NN O
: NN NN O

1 NN NN O
. NN NN O
Paxil NNP NNP B-TREATMENT
40 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
once NNP NNP B-FREQUENCY
daily NNP NNP I-FREQUENCY
. NN NN O

2 NN NN O
. NN NN O
Cozaar NNP NNP B-TREATMENT
. NN NN O

3 NN NN O
. NN NN O
Xanax NNP NNP B-TREATMENT
1 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
four NNP NNP B-FREQUENCY
times NNP NNP I-FREQUENCY
a NNP NNP I-FREQUENCY
day NNP NNP I-FREQUENCY
. NN NN O

4 NN NN O
. NN NN O
Prozac NNP NNP B-TREATMENT
20 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
a NNP NNP B-FREQUENCY
day NNP NNP I-FREQUENCY
. NN NN O

5 NN NN O
. NN NN O
Lasix NNP NNP B-TREATMENT
40 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
a NNP NNP B-FREQUENCY
day NNP NNP I-FREQUENCY
. NN NN O

6 NN NN O
. NN NN O
Potassium NNP NNP B-TREATMENT
10 NNP NNP B-STRENGTH
mEq NNP NNP I-STRENGTH
a NNP NNP B-FREQUENCY
day NNP NNP I-FREQUENCY
. NN NN O

7 NN NN O
. NN NN O
Mirapex NNP NNP B-TREATMENT
two NNP NNP B-DOSAGE
tablets NNP NNP B-FORM
every NNP NNP B-FREQUENCY
night NNP NNP I-FREQUENCY
. NN NN O

8 NN NN O
. NN NN O
Allegra NNP NNP B-TREATMENT
60 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
twice NNP NNP B-FREQUENCY
a NNP NNP I-FREQUENCY
day NNP NNP I-FREQUENCY
. NN NN O

9 NN NN O
. NN NN O
Avandamet NNP NNP B-TREATMENT
4/1000 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
daily NNP NNP B-FREQUENCY
. NN NN O

10 NN NN O
. NN NN O
Nexium NNP NNP B-TREATMENT
20 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
a NNP NNP B-FREQUENCY
day NNP NNP I-FREQUENCY
. NN NN O

11 NN NN O
. NN NN O
NovoLog NNP NNP B-TREATMENT
25/50 NNP NNP B-STRENGTH
. NN NN O

REVIEW NN NN O
OF NN NN O
SYSTEMS NN NN O
: NN NN O
Fatigue NNP NNP B-PROBLEM
, NN NN O
occasional NNP NNP B-PROBLEM
rectal NNP NNP I-PROBLEM
bleeding NNP NNP I-PROBLEM
, NN NN O
and NN NN O
obesity NNP NNP B-PROBLEM
. NN NN O

Other NN NN O
systems NN NN O
were NN NN O
reviewed NN NN O
and NN NN O
were NN NN O
found NN NN O
to NN NN O
be NN NN O
unremarkable NN NN O
. NN NN O

PHYSICAL NN NN O
EXAMINATION NN NN O
: NN NN O
VITAL NN NN O
SIGNS NN NN O
: NN NN O
Today NN NN O
revealed NN NN O
that NN NN O
temperature NNP NNP B-TEST
35.8 NN NN O
, NN NN O
blood NNP NNP B-TEST
pressure NNP NNP I-TEST
120/49 NN NN O
, NN NN O
pulse NNP NNP B-TEST
85 NN NN O
, NN NN O
and NN NN O
respirations NNP NNP B-TEST

18 NN NN O
. NN NN O
HEENT NN NN O
: NN NN O
Oral NN NN O
cavity NN NN O
, NN NN O
no NN NN O
mucositis NNP NNP B-PROBLEM
. NN NN O

NECK NN NN O
: NN NN O
No NN NN O
nodes NNP NNP B-PROBLEM
. NN NN O

AXILLA NNP NNP B-DRUG
: NN NN O
No NN NN O
nodes NNP NNP B-PROBLEM
. NN NN O

LUNGS NN NN O
: NN NN O
Clear NN NN O
. NN NN O

CARDIAC NN NN O
: NN NN O
Regular NN NN O
rate NN NN O
and NN NN O
rhythm NN NN O
without NN NN O
murmurs NNP NNP B-PROBLEM
. NN NN O

ABDOMEN NN NN O
: NN NN O
No NN NN O
palpable NNP NNP B-PROBLEM
masses NNP NNP I-PROBLEM
. NN NN O

Morbid NNP NNP B-PROBLEM
obesity NNP NNP I-PROBLEM
. NN NN O

EXTREMITIES NN NN O
: NN NN O
Mild NNP NNP B-PROBLEM
lower NNP NNP I-PROBLEM
extremity NNP NNP I-PROBLEM
edema NNP NNP I-PROBLEM
. NN NN O

SKIN NN NN O
: NN NN O
Mild NNP NNP B-PROBLEM
dryness NNP NNP I-PROBLEM
. NN NN O

CNS NN NN O
: NN NN O
Grossly NN NN O
intact NN NN O
. NN NN O

LABORATORY NN NN O
DATA NN NN O
: NN NN O
White NNP NNP B-TEST
count NNP NNP I-TEST
4.4 NN NN O
, NN NN O
hemoglobin NNP NNP B-TEST
10.1 NN NN O
, NN NN O
platelet NNP NNP B-TEST
count NNP NNP I-TEST
132,000 NN NN O
, NN NN O
sodium NNP NNP B-TEST
135 NN NN O
, NN NN O
potassium NNP NNP B-TEST
3.9 NN NN O
, NN NN O
chloride NNP NNP B-TEST
105 NN NN O
, NN NN O
bicarbonate NNP NNP B-TEST
24 NN NN O
, NN NN O
BUN NNP NNP B-TEST
15 NN NN O
, NN NN O
and NN NN O
creatinine NNP NNP B-TEST
0.9 NN NN O
. NN NN O

Normal NN NN O
alkaline NN NN O
phosphatase NN NN O
203 NN NN O
, NN NN O
AST NNP NNP B-TEST
58 NN NN O
, NN NN O
and NN NN O
ALT NNP NNP B-TEST

31 NN NN O
. NN NN O
ASSESSMENT NN NN O
AND NN NN O
PLAN NN NN O
: NN NN O

1 NN NN O
. NN NN O
The NN NN O
patient NN NN O
with NN NN O
mantle NNP NNP B-PROBLEM
cell NNP NNP I-PROBLEM
lymphoma NNP NNP I-PROBLEM
who NN NN O
is NN NN O
4-1/2 NN NN O
years NN NN O
post NN NN O
allotransplant NNP NNP B-TREATMENT
. NN NN O

He NN NN O
is NN NN O
without NN NN O
evidence NN NN O
of NN NN O
disease NNP NNP B-PROBLEM
at NN NN O
the NN NN O
present NN NN O
time NN NN O
. NN NN O

Since NN NN O
he NN NN O
is NN NN O
4-1/2 NN NN O
years NN NN O
posttransplant NN NN O
, NN NN O
I NN NN O
do NN NN O
not NN NN O
plan NN NN O
to NN NN O
scan NNP NNP B-TEST
him NN NN O
or NN NN O
obtain NN NN O
chimerisms NNP NNP B-PROBLEM
unless NN NN O
there NN NN O
is NN NN O
reason NN NN O
to NN NN O
. NN NN O

2 NN NN O
. NN NN O
He NN NN O
is NN NN O
slightly NNP NNP B-PROBLEM
anemic NNP NNP I-PROBLEM
, NN NN O
may NN NN O
be NN NN O
iron NNP NNP B-PROBLEM
deficient NNP NNP I-PROBLEM
. NN NN O

He NN NN O
has NN NN O
had NN NN O
recurrent NNP NNP B-PROBLEM
rectal NNP NNP I-PROBLEM
bleeding NNP NNP I-PROBLEM
. NN NN O

I NN NN O
told NN NN O
him NN NN O
to NN NN O
take NN NN O
multivitamin NNP NNP B-TREATMENT
with NN NN O
iron NNP NNP B-TREATMENT
and NN NN O
see NN NN O
how NN NN O
that NN NN O
helps NN NN O
the NNP NNP B-PROBLEM
anemia NNP NNP I-PROBLEM
. NN NN O

3 NN NN O
. NN NN O
Regarding NN NN O
the NNP NNP B-PROBLEM
hematochezia NNP NNP I-PROBLEM
, NN NN O
he NN NN O
had NN NN O
an NNP NNP B-TEST
endoscopy NNP NNP I-TEST
. NN NN O

I NN NN O
reviewed NN NN O
the NN NN O
results NN NN O
from NN NN O
the NNP NNP B-TEST
previous NNP NNP I-TEST
endoscopy NNP NNP I-TEST
. NN NN O

It NN NN O
appears NN NN O
that NN NN O
he NN NN O
has NN NN O
polyps NNP NNP B-PROBLEM
, NN NN O
but NN NN O
there NN NN O
is NN NN O
no NN NN O
evidence NN NN O
of NN NN O
graft NNP NNP B-TREATMENT
versus NN NN O
host NNP NNP B-PROBLEM
disease NNP NNP I-PROBLEM
. NN NN O

4 NN NN O
. NN NN O
Regarding NN NN O
the NNP NNP B-PROBLEM
fatigue NNP NNP I-PROBLEM
, NN NN O
I NN NN O
just NN NN O
reassured NN NN O
him NN NN O
that NN NN O
he NN NN O
should NN NN O
increase NNP NNP B-PROBLEM
his NNP NNP I-PROBLEM
activity NNP NNP I-PROBLEM
level NNP NNP I-PROBLEM
, NN NN O
but NN NN O
I NN NN O
am NN NN O
not NN NN O
sure NN NN O
how NN NN O
realistic NN NN O
that NN NN O
is NN NN O
going NN NN O
to NN NN O
be NN NN O
. NN NN O

5 NN NN O
. NN NN O
He NN NN O
is NN NN O
followed NN NN O
for NN NN O
his NNP NNP B-PROBLEM
diabetes NNP NNP I-PROBLEM
by NN NN O
his NN NN O
internist NN NN O
. NN NN O

6 NN NN O
. NN NN O
If NN NN O
he NN NN O
should NN NN O
have NN NN O
any NNP NNP B-PROBLEM
fever NNP NNP I-PROBLEM
or NN NN O
anything NN NN O
suggestive NN NN O
of NN NN O
infection NNP NNP B-PROBLEM
, NN NN O
I NN NN O
advised NN NN O
him NN NN O
to NN NN O
call NN NN O
me NN NN O
. NN NN O

I NN NN O
will NN NN O
see NN NN O
him NN NN O
back NN NN O
in NN NN O
about NN NN O
2 NN NN O
months NN NN O
from NN NN O
now NN NN O
. NN NN O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Parathyroid NNP NNP B-PROBLEM
Adenoma NNP NNP I-PROBLEM
Excision NNP NNP I-PROBLEM
Description NN NN O
: NN NN O
Excision NNP NNP B-TREATMENT
of NN NN O
right NNP NNP B-PROBLEM
superior NNP NNP I-PROBLEM
parathyroid NNP NNP I-PROBLEM
adenoma NNP NNP I-PROBLEM
, NN NN O
seen NN NN O
on NN NN O
sestamibi NNP NNP B-TEST
parathyroid NNP NNP I-TEST
scan NNP NNP I-TEST
and NN NN O
an NNP NNP B-TEST
ultrasound NNP NNP I-TEST
. NN NN O

( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
PREOPERATIVE NN NN O
DIAGNOSIS NN NN O
: NN NN O
Right NNP NNP B-PROBLEM
superior NNP NNP I-PROBLEM
parathyroid NNP NNP I-PROBLEM
adenoma NNP NNP I-PROBLEM
. NN NN O

POSTOPERATIVE NN NN O
DIAGNOSIS NN NN O
: NN NN O
Right NNP NNP B-PROBLEM
superior NNP NNP I-PROBLEM
parathyroid NNP NNP I-PROBLEM
adenoma NNP NNP I-PROBLEM
. NN NN O

PROCEDURE NN NN O
: NN NN O
Excision NNP NNP B-TREATMENT
of NN NN O
right NNP NNP B-PROBLEM
superior NNP NNP I-PROBLEM
parathyroid NNP NNP I-PROBLEM
adenoma NNP NNP I-PROBLEM
. NN NN O

ANESTHESIA NN NN O
: NN NN O
Local NN NN O
with NN NN O
1% NNP NNP B-TREATMENT
Xylocaine NNP NNP I-TREATMENT
and NN NN O
anesthesia NNP NNP B-TREATMENT
standby NNP NNP I-TREATMENT
with NN NN O
sedation NNP NNP B-TREATMENT
. NN NN O

CLINICAL NN NN O
HISTORY NN NN O
: NN NN O
This NN NN O
80-year-old NNP NNP B-AGE
woman NN NN O
has NN NN O
had NN NN O
some NNP NNP B-PROBLEM
mild NNP NNP I-PROBLEM
dementia NNP NNP I-PROBLEM
. NN NN O

She NN NN O
was NN NN O
begun NN NN O
on NN NN O
Aricept NNP NNP B-TREATMENT
but NN NN O
could NN NN O
not NN NN O
tolerate NN NN O
that NN NN O
because NN NN O
of NN NN O
strange NNP NNP B-PROBLEM
thoughts NNP NNP I-PROBLEM
and NN NN O
hallucinations NNP NNP B-PROBLEM
. NN NN O

She NN NN O
was NN NN O
found NN NN O
to NN NN O
be NN NN O
hypercalcemic NNP NNP B-PROBLEM
. NN NN O

Intact NNP NNP B-TEST
PTH NNP NNP I-TEST
was NN NN O
mildly NNP NNP B-PROBLEM
elevated NNP NNP I-PROBLEM
. NN NN O

A NNP NNP B-TEST
sestamibi NNP NNP I-TEST
parathyroid NNP NNP I-TEST
scan NNP NNP I-TEST
and NN NN O
an NNP NNP B-TEST
ultrasound NNP NNP I-TEST
showed NN NN O
evidence NN NN O
of NN NN O
a NNP NNP B-PROBLEM
right NNP NNP I-PROBLEM
superior NNP NNP I-PROBLEM
parathyroid NNP NNP I-PROBLEM
adenoma NNP NNP I-PROBLEM
. NN NN O

FINDINGS NN NN O
AND NN NN O
PROCEDURE NN NN O
: NN NN O
The NN NN O
patient NN NN O
was NN NN O
placed NN NN O
on NN NN O
the NN NN O
operating NN NN O
table NN NN O
in NN NN O
the NN NN O
supine NN NN O
position NN NN O
. NN NN O

A NN NN O
time NN NN O
out NN NN O
was NN NN O
taken NN NN O
so NN NN O
that NN NN O
the NN NN O
anesthesia NN NN O
personnel NN NN O
, NN NN O
nursing NNP NNP B-PROFESSION
personnel NNP NNP I-PROFESSION
, NN NN O
surgical NN NN O
team NN NN O
, NN NN O
and NN NN O
patient NN NN O
could NN NN O
confirm NN NN O
the NN NN O
patient's NN NN O
identity NN NN O
, NN NN O
operative NNP NNP B-PROBLEM
site NNP NNP I-PROBLEM
and NN NN O
operative NN NN O
plan NN NN O
. NN NN O

The NN NN O
electronic NN NN O
medical NN NN O
record NN NN O
was NN NN O
reviewed NN NN O
as NN NN O
was NN NN O
the NNP NNP B-TEST
ultrasound NNP NNP I-TEST
. NN NN O

The NN NN O
patient NN NN O
was NN NN O
sedated NNP NNP B-TREATMENT
. NN NN O

A NNP NNP B-TREATMENT
small NNP NNP I-TREATMENT
roll NNP NNP I-TREATMENT
was NN NN O
placed NN NN O
behind NN NN O
the NN NN O
shoulders NN NN O
to NN NN O
moderately NNP NNP B-PROBLEM
hyperextend NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
neck NNP NNP I-PROBLEM
. NN NN O

The NN NN O
head NN NN O
was NN NN O
supported NN NN O
in NN NN O
a NNP NNP B-TREATMENT
foam NNP NNP I-TREATMENT
head NNP NNP I-TREATMENT
cradle NNP NNP I-TREATMENT
. NN NN O

The NN NN O
neck NN NN O
and NN NN O
chest NN NN O
were NN NN O
prepped NN NN O
with NN NN O
chlorhexidine NNP NNP B-TREATMENT
and NN NN O
isolated NN NN O
with NN NN O
sterile NNP NNP B-TREATMENT
drapes NNP NNP I-TREATMENT
. NN NN O

After NN NN O
infiltration NNP NNP B-PROBLEM
with NN NN O
1% NNP NNP B-TREATMENT
Xylocaine NNP NNP I-TREATMENT
with NN NN O
epinephrine NNP NNP B-TREATMENT
along NN NN O
the NNP NNP B-PROBLEM
planned NNP NNP I-PROBLEM
incision NNP NNP I-PROBLEM
, NN NN O
a NNP NNP B-PROBLEM
transverse NNP NNP I-PROBLEM
incision NNP NNP I-PROBLEM
was NN NN O
made NN NN O
in NN NN O
the NN NN O
skin NN NN O
crease NN NN O
a NN NN O
couple NN NN O
of NN NN O
centimeters NN NN O
above NN NN O
the NN NN O
clavicular NN NN O
heads NN NN O
and NN NN O
carried NN NN O
down NN NN O
through NN NN O
the NN NN O
skin NN NN O
, NN NN O
subcutaneous NN NN O
tissue NN NN O
, NN NN O
and NN NN O
platysma NN NN O
. NN NN O

The NN NN O
larger NN NN O
anterior NN NN O
neck NN NN O
veins NN NN O
were NN NN O
divided NN NN O
between NN NN O
4-0 NNP NNP B-TREATMENT
silk NNP NNP I-TREATMENT
ligatures NNP NNP I-TREATMENT
. NN NN O

Superior NNP NNP B-TREATMENT
and NNP NNP I-TREATMENT
inferior NNP NNP I-TREATMENT
flaps NNP NNP I-TREATMENT
were NN NN O
developed NN NN O
in NN NN O
the NN NN O
subplatysmal NN NN O
plane NN NN O
using NN NN O
electrocautery NNP NNP B-TREATMENT
and NN NN O
blunt NNP NNP B-TREATMENT
dissection NNP NNP I-TREATMENT
. NN NN O

The NN NN O
sternohyoid NN NN O
muscles NN NN O
were NN NN O
separated NN NN O
in NN NN O
the NN NN O
midline NN NN O
, NN NN O
and NN NN O
the NN NN O
right NN NN O
sternohyoid NN NN O
muscle NN NN O
was NN NN O
retracted NN NN O
laterally NN NN O
. NN NN O

The NN NN O
right NN NN O
sternothyroid NN NN O
muscle NN NN O
was NN NN O
divided NN NN O
transversely NN NN O
with NN NN O
the NNP NNP B-TREATMENT
cautery NNP NNP I-TREATMENT
. NN NN O

The NN NN O
right NN NN O
middle NN NN O
thyroid NN NN O
vein NN NN O
was NN NN O
divided NN NN O
between NN NN O
4-0 NNP NNP B-TREATMENT
silk NNP NNP I-TREATMENT
ligatures NNP NNP I-TREATMENT
. NN NN O

The NN NN O
right NN NN O
thyroid NN NN O
lobe NN NN O
was NN NN O
rotated NNP NNP B-PROBLEM
leftward NNP NNP I-PROBLEM
. NN NN O

Posterior NN NN O
to NN NN O
the NN NN O
mid NN NN O
portion NN NN O
of NN NN O
the NN NN O
left NN NN O
thyroid NN NN O
lobe NN NN O
, NN NN O
a NNP NNP B-PROBLEM
right NNP NNP I-PROBLEM
superior NNP NNP I-PROBLEM
parathyroid NNP NNP I-PROBLEM
adenoma NNP NNP I-PROBLEM
of NNP NNP I-PROBLEM
moderate NNP NNP I-PROBLEM
size NNP NNP I-PROBLEM
was NN NN O
identified NN NN O
. NN NN O

This NN NN O
was NN NN O
freed NN NN O
up NN NN O
and NN NN O
its NNP NNP B-TREATMENT
pedicle NNP NNP I-TREATMENT
was NN NN O
ligated NN NN O
with NN NN O
small NNP NNP B-TREATMENT
Hemoclips NNP NNP I-TREATMENT
and NN NN O
divided NN NN O
and NN NN O
the NN NN O
gland NN NN O
was NN NN O
removed NN NN O
. NN NN O

It NN NN O
was NN NN O
sent NN NN O
for NN NN O
weight NNP NNP B-TEST
and NN NN O
frozen NNP NNP B-TEST
section NNP NNP I-TEST
. NN NN O

It NN NN O
weighed NN NN O
960 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
and NN NN O
on NN NN O
frozen NNP NNP B-TREATMENT
section NNP NNP I-TREATMENT
was NN NN O
consistent NN NN O
with NN NN O
a NNP NNP B-PROBLEM
parathyroid NNP NNP I-PROBLEM
adenoma NNP NNP I-PROBLEM
. NN NN O

Prior NN NN O
to NN NN O
the NNP NNP B-TREATMENT
procedure NNP NNP I-TREATMENT
, NN NN O
a NNP NNP B-TEST
peripheral NNP NNP I-TEST
blood NNP NNP I-TEST
sample NNP NNP I-TEST
had NN NN O
been NN NN O
obtained NN NN O
and NN NN O
placed NN NN O
in NN NN O
a NNP NNP B-TREATMENT
purple NNP NNP I-TREATMENT
top NNP NNP I-TREATMENT
tube NNP NNP I-TREATMENT
labeled NNP NNP I-TREATMENT
" NN NN O
pre-excision NNP NNP B-TREATMENT
. NN NN O

" NN NN O
It NN NN O
was NN NN O
our NN NN O
intention NN NN O
to NN NN O
monitor NN NN O
intraoperative NN NN O
intact NN NN O
parathyroid NN NN O
hormone NN NN O
10 NN NN O
minutes NN NN O
after NN NN O
removal NNP NNP B-TREATMENT
of NN NN O
this NNP NNP B-PROBLEM
parathyroid NNP NNP I-PROBLEM
adenoma NNP NNP I-PROBLEM
. NN NN O

However NN NN O
, NN NN O
we NN NN O
could NN NN O
not NN NN O
obtain NN NN O
3 NN NN O
cc NN NN O
of NN NN O
blood NNP NNP B-PROBLEM
from NN NN O
either NN NN O
the NN NN O
left NN NN O
foot NN NN O
or NN NN O
the NN NN O
left NN NN O
arm NN NN O
after NN NN O
multiple NN NN O
attempts NN NN O
, NN NN O
and NN NN O
therefore NN NN O
, NN NN O
we NN NN O
decided NN NN O
that NN NN O
the NN NN O
chance NN NN O
of NN NN O
cure NN NN O
of NN NN O
hyperparathyroidism NNP NNP B-PROBLEM
by NN NN O
removal NNP NNP B-TREATMENT
of NN NN O
this NNP NNP B-PROBLEM
parathyroid NNP NNP I-PROBLEM
adenoma NNP NNP I-PROBLEM
was NN NN O
high NN NN O
enough NN NN O
and NN NN O
the NN NN O
improvement NN NN O
in NN NN O
that NN NN O
chance NN NN O
of NN NN O
cure NN NN O
marginal NN NN O
enough NN NN O
that NN NN O
we NN NN O
would NN NN O
terminate NN NN O
the NNP NNP B-TREATMENT
procedure NNP NNP I-TREATMENT
without NN NN O
monitoring NNP NNP B-TEST
PTH NNP NNP I-TEST
. NN NN O

The NN NN O
neck NN NN O
was NN NN O
irrigated NN NN O
with NN NN O
saline NNP NNP B-TREATMENT
and NN NN O
hemostasis NNP NNP B-TREATMENT
found NN NN O
to NN NN O
be NN NN O
satisfactory NN NN O
. NN NN O

The NN NN O
sternohyoid NN NN O
muscles NN NN O
were NN NN O
reapproximated NN NN O
with NN NN O
interrupted NN NN O
4-0 NNP NNP B-TREATMENT
Vicryl NNP NNP I-TREATMENT
. NN NN O

The NN NN O
platysma NN NN O
was NN NN O
closed NN NN O
with NN NN O
interrupted NN NN O
4-0 NNP NNP B-TREATMENT
Vicryl NNP NNP I-TREATMENT
, NN NN O
and NN NN O
the NNP NNP B-TREATMENT
skin NNP NNP I-TREATMENT
was NN NN O
closed NN NN O
with NN NN O
subcuticular NNP NNP B-TREATMENT
5-0 NNP NNP I-TREATMENT
Monocryl NNP NNP I-TREATMENT
and NN NN O
Dermabond NNP NNP B-TREATMENT
. NN NN O

The NN NN O
patient NN NN O
was NN NN O
awakened NN NN O
and NN NN O
taken NN NN O
to NN NN O
the NN NN O
recovery NN NN O
area NN NN O
in NN NN O
satisfactory NN NN O
condition NN NN O
having NN NN O
tolerated NN NN O
the NNP NNP B-TREATMENT
procedure NNP NNP I-TREATMENT
well NN NN O
. NN NN O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Non-Hodgkin NNP NNP B-PROBLEM
lymphoma NNP NNP I-PROBLEM
Followup NN NN O
Description NN NN O
: NN NN O
Follicular NNP NNP B-PROBLEM
non-Hodgkin's NNP NNP I-PROBLEM
lymphoma NNP NNP I-PROBLEM
. NN NN O

Biopsy NNP NNP B-TEST
of NNP NNP I-TEST
a NNP NNP I-TEST
left NNP NNP I-TEST
posterior NNP NNP I-TEST
auricular NNP NNP I-TEST
lymph NNP NNP I-TEST
node NNP NNP I-TEST
and NNP NNP I-TEST
pathology NNP NNP I-TEST
showed NN NN O
follicular NNP NNP B-PROBLEM
non-Hodgkin's NNP NNP I-PROBLEM
lymphoma NNP NNP I-PROBLEM
. NN NN O

Received NN NN O
six NNP NNP B-DURATION
cycles NNP NNP I-DURATION
of NN NN O
CHOP NNP NNP B-TREATMENT
chemotherapy NNP NNP I-TREATMENT
. NN NN O

( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
CHIEF NN NN O
COMPLAINT NN NN O
: NN NN O
Follicular NNP NNP B-PROBLEM
non-Hodgkin's NNP NNP I-PROBLEM
lymphoma NNP NNP I-PROBLEM
. NN NN O

HISTORY NN NN O
OF NN NN O
PRESENT NN NN O
ILLNESS NN NN O
: NN NN O
This NN NN O
is NN NN O
an NN NN O
extremely NN NN O
pleasant NN NN O
69 NNP NNP B-AGE
year-old NN NN O
gentleman NN NN O
, NN NN O
who NN NN O
I NN NN O
follow NN NN O
for NN NN O
his NNP NNP B-PROBLEM
follicular NNP NNP I-PROBLEM
lymphoma NNP NNP I-PROBLEM
. NN NN O

His NN NN O
history NN NN O
is NN NN O
that NN NN O
in NN NN O
February NNP NNP B-DATE
of NNP NNP I-DATE
1988 NNP NNP I-DATE
he NN NN O
had NN NN O
a NNP NNP B-TEST
biopsy NNP NNP I-TEST
of NN NN O
a NNP NNP B-TEST
left NNP NNP I-TEST
posterior NNP NNP I-TEST
auricular NNP NNP I-TEST
lymph NNP NNP I-TEST
node NNP NNP I-TEST
and NN NN O
pathology NNP NNP B-TEST
showed NN NN O
follicular NNP NNP B-PROBLEM
non-Hodgkin's NNP NNP I-PROBLEM
lymphoma NNP NNP I-PROBLEM
. NN NN O

From NN NN O
03/29/88 NNP NNP B-DATE
to NN NN O
08/02/88 NNP NNP B-DATE
, NN NN O
he NN NN O
received NN NN O
six NNP NNP B-DURATION
cycles NNP NNP I-DURATION
of NN NN O
CHOP NNP NNP B-TREATMENT
chemotherapy NNP NNP I-TREATMENT
. NN NN O

In NN NN O
1990 NN NN O
, NN NN O
his NNP NNP B-TEST
CT NNP NNP I-TEST
scan NNP NNP I-TEST
showed NN NN O
retroperitoneal NNP NNP B-PROBLEM
lymphadenopathy NNP NNP I-PROBLEM
. NN NN O

Therefore NN NN O
from NN NN O
04/02/90 NNP NNP B-DATE
to NN NN O
08/20/90 NNP NNP B-DATE
, NN NN O
he NN NN O
received NN NN O
seven NNP NNP B-DURATION
cycles NNP NNP I-DURATION
of NN NN O
CVP NNP NNP B-TREATMENT
. NN NN O

In NN NN O
1999 NN NN O
, NN NN O
he NN NN O
was NN NN O
treated NN NN O
with NN NN O
m-BACOD NNP NNP B-TREATMENT
. NN NN O

He NN NN O
also NN NN O
received NN NN O
radiation NNP NNP B-TREATMENT
to NNP NNP I-TREATMENT
his NNP NNP I-TREATMENT
pelvis NNP NNP I-TREATMENT
. NN NN O

On NN NN O
03/21/01 NNP NNP B-DATE
, NN NN O
he NN NN O
had NN NN O
a NNP NNP B-TEST
right NNP NNP I-TEST
cervical NNP NNP I-TEST
lymph NNP NNP I-TEST
node NNP NNP I-TEST
biopsy NNP NNP I-TEST
, NN NN O
which NN NN O
again NN NN O
showed NN NN O
follicular NNP NNP B-PROBLEM
lymphoma NNP NNP I-PROBLEM
. NN NN O

His NNP NNP B-TEST
most NNP NNP I-TEST
recent NNP NNP I-TEST
PET NNP NNP I-TEST
scan NNP NNP I-TEST
dated NN NN O
12/31/08 NNP NNP B-DATE
showed NN NN O
resolution NN NN O
of NN NN O
previously NNP NNP B-PROBLEM
described NNP NNP I-PROBLEM
hypermetabolic NNP NNP I-PROBLEM
lymph NNP NNP I-PROBLEM
nodes NNP NNP I-PROBLEM
in NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
right NNP NNP I-PROBLEM
lower NNP NNP I-PROBLEM
neck NNP NNP I-PROBLEM
. NN NN O

Overall NN NN O
, NN NN O
he NN NN O
is NN NN O
doing NN NN O
well NN NN O
. NN NN O

He NN NN O
has NN NN O
a NN NN O
good NN NN O
energy NN NN O
level NN NN O
, NN NN O
his NN NN O
ECOG NN NN O
performance NN NN O
status NN NN O
is NN NN O

0 NN NN O
. NN NN O
He NN NN O
denies NN NN O
any NN NN O
fever NNP NNP B-PROBLEM
, NN NN O
chills NNP NNP B-PROBLEM
or NN NN O
night NNP NNP B-PROBLEM
sweats NNP NNP I-PROBLEM
. NN NN O

No NN NN O
lymphadenopathy NNP NNP B-PROBLEM
. NN NN O

No NN NN O
nausea NNP NNP B-PROBLEM
or NN NN O
vomiting NNP NNP B-PROBLEM
. NN NN O

No NN NN O
change NNP NNP B-PROBLEM
in NNP NNP I-PROBLEM
bowel NNP NNP I-PROBLEM
or NNP NNP I-PROBLEM
bladder NNP NNP I-PROBLEM
habits NNP NNP I-PROBLEM
. NN NN O

CURRENT NNP NNP B-TREATMENT
MEDICATIONS NNP NNP I-TREATMENT
: NN NN O
Avelox NNP NNP B-TREATMENT
400 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
q.d NNP NNP B-FREQUENCY
. NN NN O

p.r.n NN NN O
., NN NN O
cefuroxime NNP NNP B-TREATMENT
200 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
q.d NNP NNP B-FREQUENCY
. NN NN O

to NN NN O
be NN NN O
altered NN NN O
monthly NN NN O
with NN NN O
doxycycline NNP NNP B-TREATMENT
100 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
q.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
Coumadin NNP NNP B-TREATMENT
5 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
on NN NN O
Monday NNP NNP B-DATE
and NN NN O
2.5 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
on NN NN O
all NN NN O
other NN NN O
days NN NN O
, NN NN O
dicyclomine NNP NNP B-TREATMENT
10 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
q.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
Coreg NNP NNP B-TREATMENT
6.25 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
b.i.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
Vasotec NNP NNP B-TREATMENT
2.5 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
b.i.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
Zantac NNP NNP B-TREATMENT
150 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
q.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
Claritin NNP NNP B-TREATMENT
D NNP NNP I-TREATMENT
q.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
Centrum NNP NNP B-DRUG
q.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
calcium NNP NNP B-TREATMENT
q.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
omega-3 NNP NNP B-TREATMENT
b.i.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
Metamucil NNP NNP B-TREATMENT
q.d NNP NNP B-FREQUENCY
. NN NN O

, NN NN O
and NN NN O
Lasix NNP NNP B-TREATMENT
40 NNP NNP B-STRENGTH
mg NNP NNP I-STRENGTH
t.i.d NNP NNP B-FREQUENCY
. NN NN O

ALLERGIES NN NN O
: NN NN O
No NN NN O
known NNP NNP B-PROBLEM
drug NNP NNP I-PROBLEM
allergies NNP NNP I-PROBLEM
. NN NN O

REVIEW NN NN O
OF NN NN O
SYSTEMS NN NN O
: NN NN O
As NN NN O
per NN NN O
the NN NN O
HPI NN NN O
, NN NN O
otherwise NN NN O
negative NN NN O
. NN NN O

PAST NN NN O
MEDICAL NN NN O
HISTORY NN NN O
: NN NN O

1 NN NN O
. NN NN O
He NN NN O
has NN NN O
chronic NNP NNP B-PROBLEM
lymphedema NNP NNP I-PROBLEM
of NNP NNP I-PROBLEM
the NNP NNP I-PROBLEM
bilateral NNP NNP I-PROBLEM
lower NNP NNP I-PROBLEM
extremities NNP NNP I-PROBLEM
secondary NN NN O
to NN NN O
his NNP NNP B-PROBLEM
pelvic NNP NNP I-PROBLEM
radiation NNP NNP I-PROBLEM
. NN NN O

2 NN NN O
. NN NN O
He NN NN O
had NN NN O
bilateral NNP NNP B-PROBLEM
ureteral NNP NNP I-PROBLEM
obstruction NNP NNP I-PROBLEM
and NN NN O
is NN NN O
status NN NN O
post NN NN O
a NNP NNP B-TREATMENT
stent NNP NNP I-TREATMENT
placement NNP NNP I-TREATMENT
. NN NN O

The NNP NNP B-PROBLEM
obstruction NNP NNP I-PROBLEM
was NN NN O
secondary NN NN O
to NN NN O
his NNP NNP B-PROBLEM
pelvic NNP NNP I-PROBLEM
radiation NNP NNP I-PROBLEM
. NN NN O

3 NN NN O
. NN NN O
History NN NN O
of NN NN O
congestive NNP NNP B-PROBLEM
heart NNP NNP I-PROBLEM
failure NNP NNP I-PROBLEM
. NN NN O

4 NN NN O
. NN NN O
History NN NN O
of NN NN O
schwannoma NNP NNP B-TREATMENT
resection NNP NNP I-TREATMENT
. NN NN O

It NN NN O
was NN NN O
resected NN NN O
from NN NN O
T12 NN NN O
to NN NN O
L1 NN NN O
in NN NN O
1991 NNP NNP B-DATE
. NN NN O

5 NN NN O
. NN NN O
He NN NN O
has NN NN O
chronic NNP NNP B-PROBLEM
obstruction NNP NNP I-PROBLEM
of NNP NNP I-PROBLEM
his NNP NNP I-PROBLEM
inferior NNP NNP I-PROBLEM
vena NNP NNP I-PROBLEM
cava NNP NNP I-PROBLEM
. NN NN O

6 NN NN O
. NN NN O
Recurrent NNP NNP B-PROBLEM
lower NNP NNP I-PROBLEM
extremity NNP NNP I-PROBLEM
cellulitis NNP NNP I-PROBLEM
. NN NN O

SOCIAL NN NN O
HISTORY NN NN O
: NN NN O
He NN NN O
has NN NN O
no NN NN O
tobacco NN NN O
use NN NN O
. NN NN O

No NN NN O
alcohol NN NN O
use NN NN O
. NN NN O

He NN NN O
is NN NN O
married NN NN O
. NN NN O

He NN NN O
is NN NN O
a NN NN O
retired NN NN O
Methodist NNP NNP B-PROFESSION
minister NNP NNP I-PROFESSION
. NN NN O

FAMILY NN NN O
HISTORY NN NN O
: NN NN O
His NN NN O
mother NN NN O
just NN NN O
died NN NN O
two NN NN O
days NN NN O
ago NN NN O
. NN NN O

There NN NN O
is NN NN O
no NN NN O
history NN NN O
of NN NN O
solid NNP NNP B-PROBLEM
tumors NNP NNP I-PROBLEM
or NN NN O
hematologic NNP NNP B-PROBLEM
malignancies NNP NNP I-PROBLEM
in NN NN O
his NN NN O
family NN NN O
. NN NN O

PHYSICAL NN NN O
EXAM NN NN O
: NN NN O
VIT NN NN O
: NN NN O
Height NNP NNP B-TEST
168 NN NN O
cm NN NN O
, NN NN O
weight NNP NNP B-TEST
90.5 NN NN O
kg NN NN O
, NN NN O
blood NNP NNP B-TEST
pressure NNP NNP I-TEST
106/58 NN NN O
, NN NN O
pulse NNP NNP B-TEST
68 NN NN O
, NN NN O
and NN NN O
temperature NNP NNP B-TEST
is NN NN O
97.3 NN NN O
. NN NN O

GEN NN NN O
: NN NN O
He NN NN O
is NN NN O
nontoxic NN NN O
, NN NN O
noncachectic NNP NNP B-PROBLEM
appearing NN NN O
. NN NN O

HEAD NN NN O
: NN NN O
Examined NN NN O
and NN NN O
normal NN NN O
. NN NN O

EYES NNP NNP B-PROBLEM
: NN NN O
Anicteric NNP NNP B-PROBLEM
. NN NN O

ENT NN NN O
: NN NN O
No NN NN O
oropharyngeal NNP NNP B-PROBLEM
lesions NNP NNP I-PROBLEM
. NN NN O

LYMPH NN NN O
: NN NN O
No NN NN O
cervical NNP NNP B-PROBLEM
, NNP NNP I-PROBLEM
supraclavicular NNP NNP I-PROBLEM
, NNP NNP I-PROBLEM
or NNP NNP I-PROBLEM
axillary NNP NNP I-PROBLEM
lymphadenopathy NNP NNP I-PROBLEM
. NN NN O

HEART NN NN O
: NN NN O
Regular NN NN O
S1 NN NN O
, NN NN O
S2 NN NN O
; NN NN O

no NN NN O
murmurs NNP NNP B-PROBLEM
, NN NN O
rubs NNP NNP B-PROBLEM
, NN NN O
or NN NN O
gallops NNP NNP B-PROBLEM
. NN NN O

LUNGS NN NN O
: NN NN O
Clear NN NN O
to NN NN O
auscultation NNP NNP B-TEST
bilaterally NN NN O
. NN NN O

ABDOMEN NN NN O
: NN NN O
Nontender NN NN O
, NN NN O
nondistended NNP NNP B-PROBLEM
; NN NN O

normal NN NN O
bowel NN NN O
sounds NN NN O
; NN NN O

no NN NN O
hepatosplenomegaly NNP NNP B-PROBLEM
. NN NN O

EXT NN NN O
: NN NN O
Reveal NNP NNP B-TREATMENT
no NN NN O
edema NNP NNP B-PROBLEM
. NN NN O

ASSESSMENT/PLAN NN NN O
: NN NN O
Follicular NNP NNP B-PROBLEM
non-Hodgkin's NNP NNP I-PROBLEM
lymphoma NNP NNP I-PROBLEM
. NN NN O

His NNP NNP B-TEST
CBC NNP NNP I-TEST
and NN NN O
CMP NNP NNP B-TEST
are NN NN O
acceptable NN NN O
and NN NN O
LDH NNP NNP B-TEST
is NN NN O
121 NN NN O
. NN NN O

Overall NN NN O
, NN NN O
he NN NN O
is NN NN O
doing NN NN O
well NN NN O
. NN NN O

When NN NN O
I NN NN O
see NN NN O
him NN NN O
again NN NN O
in NN NN O
three NN NN O
months NN NN O
, NN NN O
I NN NN O
will NN NN O
repeat NN NN O
his NNP NNP B-TEST
laboratory NNP NNP I-TEST
studies NNP NNP I-TEST
as NN NN O
well NN NN O
his NNP NNP B-TEST
PET NNP NNP I-TEST
scan NNP NNP I-TEST
. NN NN O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Iron NNP NNP B-PROBLEM
deficiency NNP NNP I-PROBLEM
anemia NNP NNP I-PROBLEM
Description NN NN O
: NN NN O
Iron NNP NNP B-PROBLEM
deficiency NNP NNP I-PROBLEM
anemia NNP NNP I-PROBLEM
. NN NN O

She NN NN O
underwent NN NN O
a NNP NNP B-TEST
bone NNP NNP I-TEST
marrow NNP NNP I-TEST
biopsy NNP NNP I-TEST
which NN NN O
showed NN NN O
a NN NN O
normal NN NN O
cellular NN NN O
marrow NN NN O
with NN NN O
trilineage NNP NNP B-PROBLEM
hematopoiesis NNP NNP I-PROBLEM
. NN NN O

( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
CHIEF NN NN O
COMPLAINT NN NN O
: NN NN O
Iron NNP NNP B-PROBLEM
deficiency NNP NNP I-PROBLEM
anemia NNP NNP I-PROBLEM
. NN NN O

HISTORY NN NN O
OF NN NN O
PRESENT NN NN O
ILLNESS NN NN O
: NN NN O
This NN NN O
is NN NN O
a NN NN O
very NN NN O
pleasant NN NN O
19-year-old NNP NNP B-AGE
woman NN NN O
, NN NN O
who NN NN O
was NN NN O
recently NN NN O
hospitalized NN NN O
with NN NN O
iron NNP NNP B-PROBLEM
deficiency NNP NNP I-PROBLEM
anemia NNP NNP I-PROBLEM
. NN NN O

She NN NN O
was NN NN O
seen NN NN O
in NN NN O
consultation NN NN O
by NN NN O
Dr NN NN O
. NN NN O
X NN NN O
. NN NN O
She NN NN O
underwent NN NN O
a NNP NNP B-TEST
bone NNP NNP I-TEST
marrow NNP NNP I-TEST
biopsy NNP NNP I-TEST
on NN NN O
07/21/10 NNP NNP B-DATE
, NN NN O
which NN NN O
showed NN NN O
a NN NN O
normal NN NN O
cellular NN NN O
marrow NN NN O
with NN NN O
trilineage NNP NNP B-PROBLEM
hematopoiesis NNP NNP I-PROBLEM
. NN NN O

On NN NN O
07/22/10 NNP NNP B-DATE
, NN NN O
her NNP NNP B-TEST
hemoglobin NNP NNP I-TEST
was NN NN O
6.5 NN NN O
and NN NN O
therefore NN NN O
she NN NN O
was NN NN O
transfused NN NN O
2 NNP NNP B-DOSAGE
units NNP NNP I-DOSAGE
of NN NN O
packed NNP NNP B-TREATMENT
red NNP NNP I-TREATMENT
blood NNP NNP I-TREATMENT
cells NNP NNP I-TREATMENT
. NN NN O

Her NNP NNP B-TEST
iron NNP NNP I-TEST
levels NNP NNP I-TEST
were NN NN O
5 NN NN O
and NN NN O
her NNP NNP B-TEST
percent NNP NNP I-TEST
transferrin NNP NNP I-TEST
was NN NN O

2 NN NN O
. NN NN O
There NN NN O
was NN NN O
no NN NN O
evidence NN NN O
of NN NN O
hemolysis NNP NNP B-PROBLEM
. NN NN O

Of NN NN O
note NN NN O
, NN NN O
she NN NN O
had NN NN O
a NN NN O
baby NN NN O
5 NN NN O
months NN NN O
ago NN NN O
; NN NN O

however NN NN O
she NN NN O
does NN NN O
not NN NN O
describe NN NN O
excessive NNP NNP B-PROBLEM
bleeding NNP NNP I-PROBLEM
at NN NN O
the NN NN O
time NN NN O
of NN NN O
birth NN NN O
. NN NN O

She NN NN O
currently NN NN O
has NN NN O
an NNP NNP B-TREATMENT
IUD NNP NNP I-TREATMENT
, NN NN O
so NN NN O
she NN NN O
is NN NN O
not NN NN O
menstruating NN NN O
. NN NN O

She NN NN O
was NN NN O
discharged NN NN O
from NN NN O
the NN NN O
hospital NN NN O
on NN NN O
iron NNP NNP B-TREATMENT
supplements NNP NNP I-TREATMENT
. NN NN O

She NN NN O
denies NN NN O
any NN NN O
fevers NNP NNP B-PROBLEM
, NN NN O
chills NNP NNP B-PROBLEM
, NN NN O
or NN NN O
night NNP NNP B-PROBLEM
sweats NNP NNP I-PROBLEM
. NN NN O

No NN NN O
lymphadenopathy NNP NNP B-PROBLEM
. NN NN O

No NN NN O
nausea NNP NNP B-PROBLEM
or NN NN O
vomiting NNP NNP B-PROBLEM
. NN NN O

No NN NN O
change NNP NNP B-PROBLEM
in NNP NNP I-PROBLEM
bowel NNP NNP I-PROBLEM
or NNP NNP I-PROBLEM
bladder NNP NNP I-PROBLEM
habits NNP NNP I-PROBLEM
. NN NN O

She NN NN O
specifically NN NN O
denies NN NN O
melena NNP NNP B-PROBLEM
or NN NN O
hematochezia NNP NNP B-PROBLEM
. NN NN O

CURRENT NN NN O
MEDICATIONS NN NN O
: NN NN O
Iron NNP NNP B-TREATMENT
supplements NNP NNP I-TREATMENT
and NN NN O
Levaquin NNP NNP B-TREATMENT
. NN NN O

ALLERGIES NN NN O
: NN NN O
Penicillin NNP NNP B-TREATMENT
. NN NN O

REVIEW NN NN O
OF NN NN O
SYSTEMS NN NN O
: NN NN O
As NN NN O
per NN NN O
the NN NN O
HPI NN NN O
, NN NN O
otherwise NN NN O
negative NN NN O
. NN NN O

PAST NN NN O
MEDICAL NN NN O
HISTORY NN NN O
: NN NN O
She NN NN O
is NN NN O
status NN NN O
post NN NN O
birth NN NN O
of NN NN O
a NN NN O
baby NN NN O
girl NN NN O
5 NN NN O
months NN NN O
ago NN NN O
. NN NN O

She NN NN O
is NN NN O
G1 NN NN O
, NN NN O
P1 NN NN O
. NN NN O

She NN NN O
is NN NN O
currently NN NN O
using NN NN O
an NNP NNP B-TREATMENT
IUD NNP NNP I-TREATMENT
for NN NN O
contraception NNP NNP B-TREATMENT
. NN NN O

SOCIAL NN NN O
HISTORY NN NN O
: NN NN O
She NN NN O
has NN NN O
no NN NN O
tobacco NN NN O
use NN NN O
. NN NN O

She NN NN O
has NN NN O
rare NN NN O
alcohol NN NN O
use NN NN O
. NN NN O

No NN NN O
illicit NN NN O
drug NN NN O
use NN NN O
. NN NN O

FAMILY NN NN O
HISTORY NN NN O
: NN NN O
Her NN NN O
maternal NN NN O
grandmother NN NN O
had NN NN O
stomach NNP NNP B-PROBLEM
cancer NNP NNP I-PROBLEM
. NN NN O

There NN NN O
is NN NN O
no NN NN O
history NN NN O
of NN NN O
hematologic NNP NNP B-PROBLEM
malignancies NNP NNP I-PROBLEM
. NN NN O

PHYSICAL NN NN O
EXAM NN NN O
: NN NN O
GEN NN NN O
: NN NN O
She NN NN O
is NN NN O
nontoxic NN NN O
, NN NN O
noncachectic NNP NNP B-PROBLEM
appearing NN NN O
. NN NN O

HEAD NN NN O
: NN NN O
Examined NN NN O
and NN NN O
normal NN NN O
. NN NN O

EYES NNP NNP B-PROBLEM
: NN NN O
Anicteric NNP NNP B-PROBLEM
. NN NN O

ENT NN NN O
: NN NN O
No NN NN O
oropharyngeal NNP NNP B-PROBLEM
lesions NNP NNP I-PROBLEM
. NN NN O

LYMPH NN NN O
: NN NN O
No NN NN O
cervical NNP NNP B-PROBLEM
, NNP NNP I-PROBLEM
supraclavicular NNP NNP I-PROBLEM
, NNP NNP I-PROBLEM
or NNP NNP I-PROBLEM
axillary NNP NNP I-PROBLEM
lymphadenopathy NNP NNP I-PROBLEM
. NN NN O

HEART NN NN O
: NN NN O
Regular NN NN O
S1 NN NN O
, NN NN O
S2 NN NN O
; NN NN O

no NN NN O
murmurs NNP NNP B-PROBLEM
, NN NN O
rubs NNP NNP B-PROBLEM
, NN NN O
or NN NN O
gallops NNP NNP B-PROBLEM
. NN NN O

LUNGS NN NN O
: NN NN O
Clear NN NN O
to NN NN O
auscultation NNP NNP B-TEST
bilaterally NN NN O
. NN NN O

ABDOMEN NN NN O
: NN NN O
Nontender NN NN O
, NN NN O
nondistended NNP NNP B-PROBLEM
; NN NN O

normal NN NN O
bowel NN NN O
sounds NN NN O
; NN NN O

no NN NN O
hepatosplenomegaly NNP NNP B-PROBLEM
. NN NN O

EXT NN NN O
: NN NN O
Reveal NNP NNP B-TREATMENT
no NN NN O
edema NNP NNP B-PROBLEM
. NN NN O

ASSESSMENT/PLAN NN NN O
: NN NN O
Iron NNP NNP B-PROBLEM
deficiency NNP NNP I-PROBLEM
anemia NNP NNP I-PROBLEM
. NN NN O

At NN NN O
this NN NN O
point NN NN O
, NN NN O
I NN NN O
am NN NN O
going NN NN O
to NN NN O
schedule NN NN O
her NN NN O
for NN NN O
an NNP NNP B-TEST
EGD NNP NNP I-TEST
and NN NN O
a NNP NNP B-TEST
colonscopy NNP NNP I-TEST
. NN NN O

I NN NN O
am NN NN O
also NN NN O
going NN NN O
to NN NN O
repeat NN NN O
her NNP NNP B-TEST
iron NNP NNP I-TEST
studies NNP NNP I-TEST
. NN NN O

She NN NN O
had NN NN O
a NNP NNP B-TEST
CBC NNP NNP I-TEST
from NN NN O
yesterday NN NN O
, NN NN O
which NN NN O
showed NN NN O
hemoglobin NNP NNP B-TEST
of NN NN O
10.4 NN NN O
. NN NN O

Her NNP NNP B-TEST
MCV NNP NNP I-TEST
was NN NN O
still NNP NNP B-PROBLEM
low NNP NNP I-PROBLEM
at NN NN O
74.2 NN NN O
and NN NN O
the NNP NNP B-TEST
mean NNP NNP I-TEST
cell NNP NNP I-TEST
hemoglobin NNP NNP I-TEST
was NN NN O
25.0 NN NN O
. NN NN O

I NN NN O
would NN NN O
also NN NN O
like NN NN O
to NN NN O
check NN NN O
her NNP NNP B-TEST
fecal NNP NNP I-TEST
occult NNP NNP I-TEST
blood NNP NNP I-TEST
test NNP NNP I-TEST
x3 NN NN O
. NN NN O

I NN NN O
believe NN NN O
with NN NN O
her NNP NNP B-PROBLEM
low NNP NNP I-PROBLEM
iron NNP NNP I-PROBLEM
levels NNP NNP I-PROBLEM
it NN NN O
is NN NN O
going NN NN O
to NN NN O
be NN NN O
very NN NN O
difficult NN NN O
for NN NN O
her NN NN O
to NN NN O
replace NN NN O
it NNP NNP B-TREATMENT
orally NNP NNP I-TREATMENT
. NN NN O

I NN NN O
believe NN NN O
she NN NN O
may NN NN O
need NN NN O
intravenous NNP NNP B-TREATMENT
iron NNP NNP I-TREATMENT
infusions NNP NNP I-TREATMENT
. NN NN O

If NN NN O
that NN NN O
is NN NN O
case NN NN O
, NN NN O
we NN NN O
can NN NN O
arrange NN NN O
for NN NN O
her NN NN O
to NN NN O
find NN NN O
a NN NN O
doctor NN NN O
who NN NN O
can NN NN O
give NN NN O
the NNP NNP B-TREATMENT
iron NNP NNP I-TREATMENT
infusions NNP NNP I-TREATMENT
. NN NN O

She NN NN O
will NN NN O
follow NN NN O
up NN NN O
with NN NN O
Dr NN NN O
. NN NN O
X NN NN O
. NN NN O

Sample NN NN O
Type NN NN O
/ NN NN O
Medical NN NN O
Specialty NN NN O
: NN NN O
Hematology NN NN O
- NN NN O
Oncology NN NN O
Sample NN NN O
Name NN NN O
: NN NN O
Biopsy NNP NNP B-TEST
- NN NN O
Cervical NN NN O
Lymph NN NN O
Node NN NN O
Description NN NN O
: NN NN O
Excisional NNP NNP B-TEST
biopsy NNP NNP I-TEST
of NNP NNP I-TEST
right NNP NNP I-TEST
cervical NNP NNP I-TEST
lymph NNP NNP I-TEST
node NNP NNP I-TEST
. NN NN O

( NN NN O
Medical NN NN O
Transcription NN NN O
Sample NN NN O
Report NN NN O
) NN NN O
PREOPERATIVE NN NN O
DIAGNOSIS NN NN O
: NN NN O
Cervical NNP NNP B-PROBLEM
lymphadenopathy NNP NNP I-PROBLEM
. NN NN O

POSTOPERATIVE NN NN O
DIAGNOSIS NN NN O
: NN NN O
Cervical NNP NNP B-PROBLEM
lymphadenopathy NNP NNP I-PROBLEM
. NN NN O

PROCEDURE NN NN O
: NN NN O
Excisional NNP NNP B-TEST
biopsy NNP NNP I-TEST
of NNP NNP I-TEST
right NNP NNP I-TEST
cervical NNP NNP I-TEST
lymph NNP NNP I-TEST
node NNP NNP I-TEST
. NN NN O

ANESTHESIA NN NN O
: NN NN O
General NNP NNP B-TREATMENT
endotracheal NNP NNP I-TREATMENT
anesthesia NNP NNP I-TREATMENT
. NN NN O

SPECIMEN NN NN O
: NN NN O
Right NNP NNP B-PROBLEM
cervical NNP NNP I-PROBLEM
lymph NNP NNP I-PROBLEM
node NNP NNP I-PROBLEM
. NN NN O

EBL NNP NNP B-TEST
: NN NN O
10 NN NN O
cc NN NN O
. NN NN O

COMPLICATIONS NN NN O
: NN NN O
None NN NN O
. NN NN O

FINDINGS NN NN O
: NN NN O
Enlarged NNP NNP B-PROBLEM
level NNP NNP I-PROBLEM
2 NNP NNP I-PROBLEM
lymph NNP NNP I-PROBLEM
node NNP NNP I-PROBLEM
was NN NN O
identified NN NN O
and NN NN O
removed NN NN O
and NN NN O
sent NN NN O
for NN NN O
pathologic NNP NNP B-TEST
examination NNP NNP I-TEST
. NN NN O

FLUIDS NN NN O
: NN NN O
Please NN NN O
see NN NN O
anesthesia NN NN O
report NN NN O
. NN NN O

URINE NN NN O
OUTPUT NN NN O
: NN NN O
None NN NN O
recorded NN NN O
during NN NN O
the NN NN O
case NN NN O
. NN NN O

INDICATIONS NN NN O
FOR NN NN O
PROCEDURE NN NN O
: NN NN O
This NN NN O
is NN NN O
a NN NN O
43-year-old NNP NNP B-AGE
female NN NN O
with NN NN O
a NN NN O
several-year NN NN O
history NN NN O
of NN NN O
persistent NNP NNP B-PROBLEM
cervical NNP NNP I-PROBLEM
lymphadenopathy NNP NNP I-PROBLEM
. NN NN O

She NN NN O
reports NN NN O
that NN NN O
it NN NN O
is NN NN O
painful NNP NNP B-PROBLEM
to NN NN O
palpation NNP NNP B-TEST
on NNP NNP I-TEST
the NNP NNP I-TEST
right NNP NNP I-TEST
and NN NN O
has NN NN O
had NN NN O
multiple NNP NNP B-TEST
CT NNP NNP I-TEST
scans NNP NNP I-TEST
as NN NN O
well NN NN O
as NN NN O
an NNP NNP B-TEST
FNA NNP NNP I-TEST
which NN NN O
were NN NN O
all NN NN O
nondiagnostic NN NN O
. NN NN O

After NN NN O
risks NN NN O
and NN NN O
benefits NN NN O
of NN NN O
surgery NNP NNP B-TREATMENT
were NN NN O
discussed NN NN O
with NN NN O
the NN NN O
patient NN NN O
, NN NN O
an NN NN O
informed NN NN O
consent NN NN O
was NN NN O
obtained NN NN O
. NN NN O

She NN NN O
was NN NN O
scheduled NN NN O
for NN NN O
an NNP NNP B-TEST
excisional NNP NNP I-TEST
biopsy NNP NNP I-TEST
of NNP NNP I-TEST
the NNP NNP I-TEST
right NNP NNP I-TEST
cervical NNP NNP I-TEST
lymph NNP NNP I-TEST
node NNP NNP I-TEST
. NN NN O

PROCEDURE NN NN O
IN NN NN O
DETAIL NN NN O
: NN NN O
The NN NN O
patient NN NN O
was NN NN O
taken NN NN O
to NN NN O
the NN NN O
operating NN NN O
room NN NN O
and NN NN O
placed NN NN O
in NN NN O
the NN NN O
supine NN NN O
position NN NN O
. NN NN O

She NN NN O
was NN NN O
anesthetized NN NN O
with NN NN O
general NNP NNP B-TREATMENT
endotracheal NNP NNP I-TREATMENT
anesthesia NNP NNP I-TREATMENT
. NN NN O

The NN NN O
neck NN NN O
was NN NN O
then NN NN O
prepped NNP NNP B-TREATMENT
and NNP NNP I-TREATMENT
draped NNP NNP I-TREATMENT
in NN NN O
the NN NN O
sterile NN NN O
fashion NN NN O
. NN NN O

Again NN NN O
, NN NN O
noted NN NN O
on NN NN O
palpation NNP NNP B-TEST
there NN NN O
was NN NN O
an NNP NNP B-PROBLEM
enlarged NNP NNP I-PROBLEM
level NNP NNP I-PROBLEM
2 NNP NNP I-PROBLEM
cervical NNP NNP I-PROBLEM
lymph NNP NNP I-PROBLEM
node NNP NNP I-PROBLEM
. NN NN O

A NNP NNP B-PROBLEM
3-cm NNP NNP I-PROBLEM
horizontal NNP NNP I-PROBLEM
incision NNP NNP I-PROBLEM
was NN NN O
made NN NN O
over NN NN O
this NN NN O
lymph NN NN O
node NN NN O
. NN NN O

Dissection NNP NNP B-TREATMENT
was NN NN O
carried NN NN O
down NN NN O
until NN NN O
the NN NN O
sternocleidomastoid NN NN O
muscle NN NN O
was NN NN O
identified NN NN O
. NN NN O

The NNP NNP B-PROBLEM
enlarged NNP NNP I-PROBLEM
lymph NNP NNP I-PROBLEM
node NNP NNP I-PROBLEM
that NN NN O
measured NN NN O
approximately NN NN O
2 NN NN O
cm NN NN O
in NN NN O
diameter NN NN O
was NN NN O
identified NN NN O
and NN NN O
was NN NN O
removed NN NN O
and NN NN O
sent NN NN O
to NN NN O
Pathology NN NN O
for NN NN O
touch NNP NNP B-TEST
prep NNP NNP I-TEST
evaluation NNP NNP I-TEST
. NN NN O

The NN NN O
area NN NN O
was NN NN O
then NN NN O
explored NN NN O
for NN NN O
any NNP NNP B-PROBLEM
other NNP NNP I-PROBLEM
enlarged NNP NNP I-PROBLEM
lymph NNP NNP I-PROBLEM
nodes NNP NNP I-PROBLEM
. NN NN O

None NN NN O
were NN NN O
identified NN NN O
, NN NN O
and NN NN O
hemostasis NNP NNP B-TREATMENT
was NN NN O
achieved NN NN O
with NN NN O
electrocautery NNP NNP B-TREATMENT
. NN NN O

A NNP NNP B-TREATMENT
quarter-inch NNP NNP I-TREATMENT
Penrose NNP NNP I-TREATMENT
drain NNP NNP I-TREATMENT
was NN NN O
placed NN NN O
in NN NN O
the NNP NNP B-PROBLEM
wound NNP NNP I-PROBLEM
. NN NN O

The NNP NNP B-PROBLEM
wound NNP NNP I-PROBLEM
was NN NN O
then NN NN O
irrigated NN NN O
and NN NN O
closed NN NN O
with NN NN O
3-0 NN NN O
interrupted NN NN O
Vicryl NNP NNP B-TREATMENT
sutures NNP NNP I-TREATMENT
for NN NN O
a NNP NNP B-TREATMENT
deep NNP NNP I-TREATMENT
closure NNP NNP I-TREATMENT
followed NN NN O
by NN NN O
a NNP NNP B-TREATMENT
running NNP NNP I-TREATMENT
4-0 NNP NNP I-TREATMENT
Prolene NNP NNP I-TREATMENT
subcuticular NNP NNP I-TREATMENT
suture NNP NNP I-TREATMENT
. NN NN O

Mastisol NNP NNP B-TREATMENT
and NN NN O
Steri-Strip NNP NNP B-TREATMENT
were NN NN O
placed NN NN O
over NN NN O
the NNP NNP B-PROBLEM
incision NNP NNP I-PROBLEM
, NN NN O
and NN NN O
sterile NNP NNP B-TREATMENT
bandage NNP NNP I-TREATMENT
was NN NN O
applied NN NN O
. NN NN O

The NN NN O
patient NN NN O
tolerated NN NN O
this NNP NNP B-TREATMENT
procedure NNP NNP I-TREATMENT
well NN NN O
and NN NN O
was NN NN O
extubated NN NN O
without NN NN O
complications NNP NNP B-PROBLEM
and NN NN O
transported NN NN O
to NN NN O
the NN NN O
recovery NN NN O
room NN NN O
in NN NN O
stable NN NN O
condition NN NN O
. NN NN O

She NN NN O
will NN NN O
return NN NN O
to NN NN O
the NN NN O
office NN NN O
tomorrow NN NN O
in NN NN O
followup NN NN O
to NN NN O
have NN NN O
the NNP NNP B-TREATMENT
Penrose NNP NNP I-TREATMENT
drain NNP NNP I-TREATMENT
removed NN NN O
. NN NN O

